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 The objective of Experiment 1 was to determine the effect of bovine follicular 
fluid (bFF) on nuclear maturation.  Treatment A (Control) oocytes were stained with 
Hoechst-33342 immediately after aspiration from follicles, whereas, oocytes in 
Treatment B were held in bFF for 12 hours at 38˚C and then stained to determine nuclear 
status.  No significant difference was detected between treatment groups.  Results 
indicate that bFF inhibits resumption of meiosis.  The objective of Experiment 2 was to 
determine the effect of bFF on embryonic development.  Oocytes in Treatment A 
(Control) were placed into in vitro maturation (IVM) for 22 hours followed by in vitro 
fertilization (IVF).  Oocytes in Treatment B were held in bFF for 12 hours at 22˚C, 
followed by IVM and then subjected to IVF.  Significantly more (P<0.0001) oocytes 
cleaved, developed into blastocysts and hatched in Treatment A compared with 
Treatment B.  Results indicate that a 12-hour holding period in bFF does not promote 
normal embryonic development.  The objective of Experiment 3 was to determine the 
effect of decreased time and concentration of bFF on embryonic development.  Treatment 
A (Control) oocytes were placed into IVM followed by IVF.  Oocytes in Treatment B 
were held in bFF, oocytes in Treatment C were held in Lactated Ringer’s Solution (LRS) 
and oocytes in Treatment D were held in a combination of bFF and LRS for 6 hours at 
22˚C, followed by IVM then by IVF.  No significant difference was detected between 
Treatments A and B when analyzing cleavage, blastocyst formation and hatching rates.  
However, significantly fewer (P<0.0001) embryos reached these stages of development 





developed to the blastocyst stage in Treatment D compared with Treatment C.  
Decreasing the amount of time that oocytes were held in bFF proved to be beneficial in 
supporting in vitro embryo production (IVP).  These findings could be advantageous 














The in vitro maturation (IVM), in vitro fertilization (IVF) and in vitro culture
(IVC) of bovine oocytes are valuable tools that can be easily applied for both research
and agricultural purposes as described by Gordon (1994).  Although modifications to
culture conditions used for oocyte maturation, fertilization and embryo development have
increased the number of bovine oocytes matured and fertilized in vitro, embryo
production is still hindered by a high loss during early development.  The number of
embryos that develop to the blastocyst stage in vitro per 100 cumulus oocyte complexes
(COCs) is substandard to that for in vivo production systems (Sirard and Lambert, 1986).
Previous work has demonstrated that ~1 of every 3 oocytes develops into a viable
blastocyst following IVM, IVF and IVC (Brackett and Zuelke, 1993).  In vivo conditions
result in higher embryonic development rates, indicating that in vitro environments are
not optimum for producing live offspring.  However, much effort has been devoted to
improvement of in vitro conditions to allow for efficient bovine embryo production,
which could be utilized in both experimental and commercial settings.
The first attempt to use in vitro matured bovine oocytes occurred over 25 years
ago when fertilization was achieved using a rabbit oviduct to capacitate bull spermatozoa
(Iritani and Niwa, 1977).  However, suitable culture conditions were later established that
allow for IVM, IVF and IVC of bovine embryos resulting in acceptable embryonic
growth rates.
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The mammalian ovary contains many more immature oocytes than could ever be
utilized for reproductive technologies such as IVF and nuclear transfer.  Thus, ovarian
oocytes are a vast resource of female gametes that could ultimately be harvested with the
goal of increasing the numbers of endangered and valuable animals.  If oocytes from
deceased animals could be rescued, the potential to produce live offspring would benefit
not only researchers, but also agricultural producers and zoological researchers
attempting to save genetically superior or endangered animals.
However, after the unanticipated death of valuable animals, the resultant
postmortem degeneration of oocytes could likely compromise being able to utilize
oocytes for animal proliferation.  To prevent unnecessary degeneration of oocytes, factors
such as time and temperature need to be considered.  In cattle, homeostatic mechanisms
regulate an environment in which temperatures vary only by tenths of a degree.
Temperatures within the developing follicle of cattle are thought to closely correspond
with the animal’s body core temperature that is slightly higher than the average rectal
temperature of 38ºC to 39.3ºC (Hewitt, 1921).  It has been noted that as temperature at
which bovine ovaries are stored decreases, in vitro embryonic development decreases
(Yang et al., 1990; Aman and Parks, 1994).  Research has also shown that as ovary
storage time increases, embryonic development decreases in water buffalo oocytes
(Ravindranatha et al., 2003).
In addition to proper ovary storage, other factors such as various holding media
and culture conditions of the oocytes need to be taken into account when wanting to
rescue genetic material from females.  Utilization of follicular fluid as a holding medium
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could be beneficial since this is the normal fluid bathing oocytes in an in vivo
environment.  Numerous research studies have analyzed follicular fluid and its
subsequent effects on oocyte developmental competence.  Follicular fluid has been
identified as a transudate of plasma with specific constituents including steroids,
glycosaminoglycans, proteins and other metabolites synthesized by the array of follicular
cells (Wise, 1987).  Follicular fluid undergoes marked alterations in all mammalian
species throughout either the estrous or menstrual cycle and regulates various functions
including oocyte meiotic inhibition (Tsafriri et al., 1982), cumulus cell expansion and
male pronuclear formation in vitro (Naito et al., 1988) and it nourishes the oocyte and its
adjacent cumulus cells (Edwards, 1974).
Since oocytes naturally acquire developmental competence in vivo while being
bathed in follicular fluid, it would only be logical to assume this might serve as an
alternative in vitro holding medium.  Several studies have proven the favorable effects of
supplementing IVM medium with follicular fluid in the pig (Naito et al., 1988), cow
(Kim et al., 1996), sheep (Sun et al., 1994) and horse (Dell’Aquila et al., 1997).
However, the stage of the reproductive cycle, size of follicles and concentrations of
follicular fluid varied among the previously mentioned studies.
The overall objective of the following studies was to determine whether follicular
fluid might serve as a holding or pre-maturation medium in which oocytes could be
maintained until they could be utilized under controlled laboratory conditions.  If
follicular fluid could function as a temporary environment for oocytes, researchers, field
zoologists and agricultural producers may some day be able to use this medium to
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preserve valuable genetic material for some time without damaging the oocytes.  This
could ultimately lead to the preservation of genetic material, which could be used to





Functions of Follicular Fluid
Follicular fluid contains numerous biochemical components that are essential for
ovarian physiology, including steroidogenesis, follicle growth and ultimate maturation of
oocytes, ovulation and oviductal transport of the oocyte.  In addition, it has been
suggested that progesterone in follicular fluid could possibly play a role in the induction
of the acrosome reaction in spermatozoa of rabbits (Edwards, 1970), stallions (Cheng et
al., 1998; Rathi et al., 2003) and bulls (Lenz et al., 1982).  However, follicular fluid does
not play a major role in inducing the acrosome reaction in human sperm cells (Mortimer
and Camenzind, 1988).  Shemesh (1979) concluded that another function of follicular
fluid was to inhibit the production of both progesterone and PGF2α.  Bovine follicular
fluid (bFF) from mid-cycle follicles inhibited prostaglandin synthetase as well as
luteinization of follicles.  However, this inhibition was not noted when follicular fluid
from preovulatory follicles was used.
Follicular fluid also functions to provide nourishment to the oocyte and granulosa
cells by facilitating transport of specialized nutrients from plasma. The dynamic
constituents of this fluid reflect both biochemical and endocrinological activity of the
follicle, thereby facilitating its role as a conductor of growth and development through
the reproductive cycle (Edwards, 1974).  As is the case with any biological fluid, the
physical characteristics of follicular fluid are the product of its chemical composition and
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reflect its isolation from physiological events occurring outside its environment.  In a
follicle, physiologic factors are influenced principally by the properties of the tissues,
which separate follicular fluid from circulation.  The permeability of the follicular wall to
water and biochemical components originating from blood can markedly alter the
composition of follicular fluid.  In addition, the ability of granulosa cells to secrete both
stimulatory and inhibitory factors as a result of metabolic processes can modify the
composition of follicular fluid.  These factors influence physical parameters such as
osmolality, color, pH, viscosity and volume of the fluid originating within the developing
follicle (Fisch et al., 1990).
It was originally proposed in 1948 that follicular fluid was merely a simple
transudate of blood that accumulated between the layers of the granulosa cells in growing
follicles (Harter, 1948).  It is now known that follicular fluid contains a large variety of
components of serum along with an array of secretions, which are synthesized by the
specialized cells of the follicular microenvironment.  As a result, the components of
follicular fluid change during growth and expansion of each follicle (Wise, 1987).
Inorganic Compound, Carbohydrate, Lipid, Vitamin and Protein Content
Follicular fluid is a slightly viscous solution with a pH reported to be 7.4, similar
to that of plasma.  Investigators have reported various elements of follicular fluid to be
similar to those found in serum, with only a few differences (Edwards, 1974; Greve et al.,
1989; Luck et al., 2001).  For example, in the cow, higher concentrations of potassium
and sodium were found in follicular fluid than in serum.  However, concentrations of
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magnesium, chloride, zinc, copper and inorganic phosphate were similar to those of
bovine serum (Petkov et al., 1969).
Biochemical analysis revealed that glucose was ~75% of the total carbohydrate
content of bFF with fructose being present as only a minor fraction (Lutwak-Mann,
1954).  Lactic acid, cholesterol, protein-bound hexoses and vitamin C were also
identified in bFF (Zachariae and Jensen, 1958).  Vitamin A has also been identified in
bFF, however, its precise function is still unclear.  A report by Schweigert and Zucker
(1988) suggested that vitamin A may be used as a physiological indicator of follicular
quality and function in cattle.  The accumulation of vitamin A in follicular fluid has been
hypothesized to influence hormone and protein synthesis during follicular development.
An array of proteins found in plasma and follicular fluid has been identified using
immunoelectrophoresis and disc-gel electrophoresis (Caravaglios and Cilotti, 1957).  The
analysis of these proteins has provided evidence that follicular fluid is in partial
equilibrium with serum (Edwards, 1974). The majority of plasma proteins are present in
bovine follicular fluid although protein concentrations were lower in bFF than in serum
(Caravaglios and Cilotti, 1957).  For example, α2-globulins were found to be similar in
concentration in follicular fluid and plasma whereas albumin and β-globulin
concentrations were lower in follicular fluid than in plasma.  Protein concentrations have
been reported to be ~75% of that of serum in the cow and 50% in human follicular fluid
(Caravaglios and Cilotti, 1957).  It has been suggested that the molecular size and shape
of the molecules influence their transmission into follicular fluid.
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Enzymes
Various enzymes have also been identified in follicular fluid with their
concentrations increasing as follicular development progresses.  Lactate dehydrogenase,
ATPase, transaminases and alkaline phosphatases have been identified in human and bFF
(Stallcup, 1970; Caucig et al., 1971).  Numerous enzymes found in follicular fluid are
involved in the catabolic transformations of compounds that originate in the follicular
wall.  Specifically, hyaluronidase, endopeptidase and collagenase are three enzymes that
exist in follicular fluid to play an important role in ovulation (Zachariae and Jensen,
1958; Rondell, 1970).
Gonadotropins and Steroids
Other important components of follicular fluid are the gonadotropic and steroid
hormones.  As a follicle grows, the numbers of gonadotropin-binding sites change in both
quantity and quality (Channing, 1972).  FSH has been shown to play a role in follicular
cell proliferation along with the development of the basement membrane.  However, FSH
and LH together promote the formation of the antrum of each follicle, in addition to
helping enable the theca interna cells to become vascularized during development
(Eshkol et al., 1970).  Steroid hormones, including estrogens, androgens and progestins,
have also been identified in follicular fluid.  A total of eight steroid hormones were found
to be present in bFF, with E2 being present in the highest concentration when follicles
reached ~15 mm in diameter (Short, 1962).  A key point is that the concentrations of
steroids found in follicular fluid vary during different stages of the reproductive cycle.
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Concentrations vary widely between different follicles in the same animal or among
animals of the same species.
Ohyama et al. (1994) identified two distinct heparin-binding polypeptides in bFF
using chromatography.  Midkine and pleitrophin concentrations were estimated to be 125
µg/l and 400 µg/l, respectively.  These two substances were classified as being heparin-
binding growth/differentiation factors, which are believed to play a role in the maturation
of ovarian follicles.  However, further research is needed to determine the exact function
of these two growth factors.
Ovary Storage
Under certain circumstances, ovaries can be harvested from the abattoir for
research studies.  When obtaining ovaries from the abattoir, there are several factors that
should not be overlooked.  These include the amount of time that ovaries are held at the
abattoir before they can be thoroughly cleansed, the transport time between the abattoir
and the laboratory and the amount of time it takes before oocytes can be properly
harvested from the follicles.  Time and temperature are two key factors that can
contribute to the detrimental effects on oocyte quality in terms of nuclear maturation and
cleavage rates following IVF.
Influence of Time and Temperature on Oocyte Maturation and Embryo Development
Solano et al. (1994) found that storing bovine ovaries at 4˚C for either 12 or 24
hours had no significant effect on the total number of oocytes that successfully matured
and cleaved after fertilization.  However, significantly fewer embryos reached the
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blastocyst stage, indicating that bovine ovaries could be stored for a short period of time
at 4˚C and still produce viable blastocysts.
In another study, bovine ovaries were stored at 37˚C,  25˚C and 4˚C for either 0,
4, 8, 16 or 24-hour holding periods (Yang et al., 1990).  Cleavage and blastocyst rates
were significantly lower for all holding periods when ovaries were stored at 4˚C
compared with those in the 37˚C and 25˚C temperature groups.  Also, there were no
significant differences observed in any of the holding periods for those ovaries stored at
25˚C although cleavage and blastocyst yield tended to decrease as holding time
increased.  Results suggested that bovine ovaries could be stored at 25˚C for at least 16
hours without reducing the ability of oocytes to be fertilized and develop to the blastocyst
stage.  This finding becomes relevant when considering transporting ovaries for research
and commercial purposes.
In an experiment conducted with feline oocytes, ovaries were stored in PBS for
24, 48 and 72 hours at 4ºC before oocyte recovery.  Wolfe and Wildt (1996) concluded
that oocytes recovered from ovaries stored at 24, 48 and 72 hours were capable of
reaching M-II, indicating that decreased temperature did not affect the meiotic
competence of feline oocytes.  However, significantly more (P<0.05) blastocysts were
produced from those oocytes that were stored in ovaries for only 24 hours compared with
those oocytes recovered from ovaries stored for 48 and 72 hours.  These results indicated
that ovaries stored at 4ºC for prolonged periods of time (48 and 72 hours) decreased the
oocytes’ developmental competence for subsequent IVF.
11
 In a similar study, feline ovaries were stored in PBS for 16 to 24 hours at 10ºC.
Oocyte maturation rates for ovaries stored for 16 to 24 hours and the nonstored controls
were not significantly different.  Results indicated that decreased temperatures did not
negatively affect the meiotic ability of domestic cat oocytes to mature (Katska-
Ksiazkiewics et al., 2003) as also shown by Wolfe and Wildt (1996).
Pollard et al. (1996) examined the effect of ambient temperatures during oocyte
recovery on the IVP of bovine embryos.  Ovaries were collected from the abattoir and
transported to the laboratory in PBS at 35˚C to 37˚C within ~1 to 1.5 hours.  Follicles
were aspirated in three rooms at which the temperature was maintained at 25˚C, 30˚C or
35˚C, respectively.  The total number of oocytes that were penetrated and normally
fertilized was not different between the three treatment groups.  However, exposing
ovaries and cumulus-oocyte complexes (COC) to ambient temperatures below 35˚C
during oocyte recovery did not decrease the cleavage rate, but it significantly reduced the
blastocyst rate.  The cleavage rate for oocytes recovered from ovaries at 25˚C, 30˚C and
35ºC was 51.4%, 48.1% and 62.0%, respectively.  However, blastocyst rates were
significantly higher when the temperature at which oocytes were aspirated increased from
25˚C (17.9%) to 30˚C (11.2%) or 35ºC (28.3%).  The authors concluded that ovaries need
to be maintained at a temperature no lower than 35˚C for oocytes to achieve their
maximum developmental potential (Pollard et al., 1996).
Contradictory results were obtained in a study conducted with sheep ovaries
(Moodie and Graham, 1991).  Storing ovaries for 4, 8 or 24 hours post-slaughter at either
5˚C, 22˚C or 37˚C was found to be detrimental to the percentage of oocytes that matured
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in vitro.  Ovaries held at 22˚C resulted in a greater number of oocytes subsequently
maturing compared with those ovaries stored at 5˚C and 37˚C.  These results suggested
the optimal temperature to store ovaries until aspiration is near room temperature
(∼22°C).
Similar findings were found in research conducted with pig ovaries.  Rosenkrank
(1993) concluded that more oocytes exhibited a greater degree of cumulus cell expansion
and obtained higher maturation rates after ovaries had been held at 20˚C during transport
to the laboratory compared with oocytes collected from ovaries that had been held at
30˚C or 37˚C.  Significantly more oocytes reached M-II when ovaries were transported at
20˚C compared with 30˚C or 37˚C.  This finding indicated that increased temperature
during ovary transport could elicit detrimental effects on oocyte quality during in vitro
studies in the pig.
In a more recent study, Yuge et al. (2003) obtained contradictory results with pig
ovaries.  Significantly fewer (P<0.05) oocytes were able to reach M-II when ovaries were
stored for 1 hour at 4˚C, 15˚C, 20˚C and 25˚C compared with those ovaries that were
stored at 30˚C.  These findings concluded that porcine ovaries stored at temperatures
lower than 30˚C was not appropriate for optimal oocyte maturation.
Influence of Temperature on M-II Oocytes
Research has been conducted to determine the exact effects of cooling oocytes to
various temperatures on subsequent competence for IVF.  Azambuja et al. (1998)
analyzed the effect of low temperature on M-II bovine oocytes.  Following IVM, oocytes
were maintained at either 39˚C (control), 20˚C, 10˚C or 0˚C for 20 minutes after which
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IVF was performed.  Cleavage rates were significantly higher (P<0.05) for oocytes
maintained at 39˚C (73.2%) compared with oocytes maintained at 20˚C (58.6%), 10˚C
(47.3%) or 0˚C (36.9%).  Blastocyst development was also significantly higher (P<0.05)
in control oocytes (16.5%) compared with those maintained at 20˚C (7.1%), 10˚C (0%) or
0˚C (0.09%).  These data demonstrate that cooling in vitro matured bovine oocytes
decreased the percentage of oocytes that undergo fertilization and subsequently develop
into blastocysts following IVF.
Liu et al. (2003) also analyzed the effect of cooling on the meiotic spindle of
porcine oocytes.  Following IVM, oocytes were cooled to either 4˚C or 24˚C for 5, 30 or
120 minutes.  Results indicated that the meiotic spindle in porcine M-II oocytes were
sensitive to a drop in temperature (4˚C) as indicated by a visible meiotic spindle in only
8% of oocytes compared with the presence of the meiotic spindle in 100% of oocytes
held at 24˚C.  Both the spindle and chromosomes were damaged during the cooling
period, and such damage was not reversible after further incubation.
In another study, human oocytes were cooled to room temperature for either a
10-minute or 30-minute time interval.  Reduction in meiotic spindle size, disorganization
of microtubules within the spindle itself and often times a complete lack of microtubules
was observed in all oocytes cooled to room temperature for 30 minutes compared with
controls that were maintained at 37˚C throughout the experiment.  Results indicated that
human oocytes were compromised if cooled to room temperature before being subjected
to IVF (Pickering et al., 1990).
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In an analogous study conducted by Lonergan et al. (1991), bovine oocytes were
cooled to room temperature for 30 minutes prior to IVF.  Unlike the human, there were
no significant differences found between cleavage and blastocyst rates in those oocytes
that were held at 37˚C compared with those that were cooled to room temperature.  It was
suggested that bovine oocytes might be slightly more tolerant to decreases in temperature
than human oocytes.  However, it has been suggested that bovine ovaries should be
maintained at no lower than 35ºC to promote optimal developmental competence of the
oocytes (Pollard et al., 1996).
Influence of Time Between Slaughter and Oocyte Retrieval
Results were obtained in mice after studying the effects of the interval between
death of the animal and removal of the ovaries on IVF outcome (Schroeder et al., 1991).
The total number of cumulus cell-enclosed oocytes decreased as the interval between
death and oocyte removal increased from 0 to 12 hours.  However, no difference was
detected in terms of oocyte maturation.  Nevertheless, cleavage rate was lower when
ovaries were collected at 9 or 12 hours after the animal’s death and blastocyst rate
decreased only after a 12-hour ovary storage period.
An experiment was conducted to determine the effect of time between slaughter
and oocyte collection on maturation (Shabpared et al., 1993).  Oocytes were collected at
5 to 6, 6 to 7 and 7 to 8 hours following slaughter.  Within 1 hour of collection, recovered
oocytes from all treatment groups were placed into maturation for 30 hours.  Results
indicated no differences between treatment groups when comparing cumulus cell
expansion and oocyte maturation rates.  However, in a more recent report, Love et al.
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(2003) found that oocytes stored within ovaries at room temperature for 15 to 18 hours
were less capable of maturing (27%) than control oocytes (72%) that were aspirated
immediately after slaughter.
Findings with the mare contradict the effects of time between slaughter and
oocyte culture on consequent nuclear maturation found in the mouse, sheep, pig and cow
(Shabpared et al., 1993).  Mare ovaries were held at 30˚C to 35˚C for either 3 to 9 hours
or 10 to 15 hours.  Interestingly, there were no differences detected between treatment
groups when comparing nuclear maturation rates (Del Campo et al., 1995).
Guignot et al. (1999) also studied the effect of time during transport of equine
ovaries on oocyte recovery rate and quality following IVM.  Excised mare ovaries were
stored for either 1.5 to 4 hours or 6 to 8 hours at 37˚C.  Significantly fewer oocytes were
recovered from ovaries stored for 1.5 to 4 hours compared with those ovaries stored for 6
to 8 hours.  Although nuclear maturation was not affected by individual storage times,
there tended to be more oocytes with intact cytoplasmic membranes found in those
ovaries only stored for 1.5 to 4 hours when compared with ovaries that had been stored
for 6 to 8 hours (Guignot et al., 1999).
More recently, Hinrichs et al. (2002) concluded that IVM rates of equine oocytes
were significantly increased when oocytes obtained from abattoir-derived ovaries were
immediately placed into maturation medium compared with oocytes that were held in
tubes containing Earle’s salts and a buffer at 22˚C to 25˚C while being transported to the
laboratory.  However, fewer oocytes that were cultured immediately were mature at 24
hours than oocytes held at room temperature.  This may be an indication that cytoplasmic
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activity can occur in oocytes that are held in medium at room temperature.  This may
ultimately lead to a faster onset of meiosis after oocytes have been placed into culture
(Hinrichs et al., 2002).
Shioya et al. (1988) examined the effect of time between slaughter and aspiration
of follicles on the developmental capability of bovine oocytes to mature and fertilize
within ligated rabbit oviducts.  Ovaries were either aspirated at the abattoir within an
average of 17 minutes after slaughter or they were transported to the laboratory in warm
saline (38˚C) where they were then aspirated an average of 162 minutes post-slaughter.
The total number of oocytes that developed to the 2-cell stage after insemination was
significantly lower (30.6%) in those ovaries aspirated 162 minutes after slaughter
compared with those recovered after only 17 minutes post-slaughter (84.6%).  Embryonic
development to the 8-cell stage was not different between the treatment groups.
However, transfer of embryos to ligated rabbit oviducts resulted in significantly more
embryos developing into blastocysts from those oocytes aspirated 17 minutes post-
slaughter (28.6%) compared with oocytes aspirated 162 minutes post-slaughter (14.3%).
This study suggested that a shorter time between slaughter and aspiration resulted in
increased blastocyst production (Shioya et al., 1988), similar to the results reported by
Blondin et al. (1997) who found that bovine oocytes collected only 4 hours after
slaughter produced significantly more blastocysts (30.5%) compared with ovaries that
were aspirated at 6 (13%) and 8 (14.7%) hours following slaughter.
It is always more beneficial for researchers to be able to obtain oocytes from live
animals in order to bypass several in vitro obstacles, one of the most important being the
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proper storage of ovaries.  However, when it is necessary to obtain oocytes from abattoir-
derived ovaries, one must keep in mind some of the factors that exert detrimental effects
to the oocytes themselves.  Previous research has illustrated that time and temperature
must be considered when storing ovaries for an extended period of time.
Ovarian Follicle Size
Steroid Concentrations
When acquiring abattoir-derived ovaries, the exact stage of the reproductive cycle
is often unknown.  In vivo oocyte competence is acquired through hormonal regulation
that ultimately causes final maturation of the oocyte and subsequent ovulation.
Production of E2 by the somatic cells of ovarian follicles is important in promoting
maturation of the oocyte (Kruip, 1985).  However, oocyte competence in vitro is acquired
through the use of complex media, therefore allowing technicians a wide variety of
follicles to choose from for the use in assisted reproductive techniques.  Consequently,
the selection of follicles that have the ability to produce sufficient amounts of E2 is
essential for IVM of bovine oocytes.  However, the concentration of steroid hormones
found in follicular fluid varies with follicle size, degree of atresia and stage of the estrous
cycle, thus making follicle selection for in vitro studies a difficult task.  Oocytes derived
from slaughterhouse ovaries constitute heterogeneous material that can lead to decreased
blastocyst rates following IVF when compared with those oocytes obtained from animals
of known reproductive status (Gordon and Lu, 1990).
A substantial increase in E2 concentration accompanied by a decrease in
testosterone is commonly detected with an increase in follicle size.  In addition, there is
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an increase in IGF-1 as follicle size increased in both porcine and bovine ovaries
(Hammond et al., 1985; Spicer et al., 1988).  This could be attributed to the fact that
IGF-1 functions to regulate follicular cell differentiation (Hazeleger et al., 1995; Austin
et al., 2001).  In a recent study, Irving-Rodgers et al. (2003) identified insulin-like growth
factor binding proteins (IGFBP) in follicular fluid collected from both healthy and atretic
bovine follicles.  The levels (per volume of follicular fluid) of IGFBP 2, 4 and 5 were not
statistically different when analyzing levels of IGFBP between healthy and atretic
follicles.  It has been hypothesized that the function of IGFBP is to alter the levels of
bioavailable IGF that stimulates steroidogenesis and mitogenesis in developing follicles
(Bridges et al., 2002).  Therefore, an increase in hormone levels in follicular fluid during
the estrous cycle may modulate follicular development and/or atresia by affecting the
synthesis or proteolysis of IGFBP.
Follicle atresia can be recognized by an increase in P4 and a decrease in E2
concentration within bFF (Ireland and Roche, 1982; Kruip, 1985).  Dominant follicles
have been shown to have high E2 and low P4 levels.  The variation in the concentration of
these steroids in follicular fluid during various stages of the cycle indicates the ability of
follicular cells to change hormone production (Dobson and Dean, 1974; Wise et al.,
1982; McNatty et al., 1984).  Altering hormone output of the follicular cells has an effect
on an oocyte’s potential to develop.
The influence of follicular size and stage of the cycle on steroid hormone
concentration in follicular fluid can be influenced by the difference in availability of LH
and FSH receptors and by the variation in LH patterns (Karsch, 1977; Roche and Ireland,
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1981; Hansel, 1983).  Although FSH primarily influences the system for androgen
aromatization, LH receptors are also found on the granulosa-cell membrane.  Both FSH
and LH have proven to be beneficial for the large production of E2 within the follicle
(England et al., 1981; Hillier, 1981; Merz et al., 1981).  Bovine follicles ranging in
diameter from 2 to 5 mm have LH receptors located in the theca interna and will produce
androgens; however, these small follicles have very few LH receptors on the granulosa-
cell membrane.  These small follicles have been termed “androgen-dominated” as a result
of the lack of LH receptors that will ultimately aromatize androgens into estrogens
(Tsonis et al., 1984).  Follicles >11 mm in diameter have been classified as “estrogen-
dominated”.  As these follicles grow, there is an increase in LH receptors in both the
theca and granulosa cells, which contribute to the increased output of E2.
The differences in steroid concentrations between follicles of various sizes can be
attributed to intrinsic factors, such as the capacity to produce steroids, and extrinsic
factors, such as the availability of gonadotropic hormones.  Therefore, a key aspect
contributing to developmental competence of oocytes is the concentration of various
hormones in follicular fluid (Sirard, 2001).
Factors Affecting Oocyte Developmental Competence
There are several ways to determine the developmental competency of an oocyte:
polar body extrusion, ICSI, cleavage rates, blastocyst formation and cumulus cell
expansion.  In addition, staining oocytes to determine their stage of nuclear maturation
can also be used to determine an oocyte’s ability to become fertilized and ultimately
develop into a viable embryo in vitro (Carnevale et al., in press).
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Studies have shown that the developmental capacity of bovine oocytes is affected
by several factors, two of which include the size (Tan and Lu, 1990; Pavlok et al., 1992;
Carolan et al., 1996 ) and quality of the follicle (Blondin and Sirard, 1994; Blondin et al.,
1997; Fouladi Nashta et al., 1998).  These factors were considered in a study that
investigated the capacity of bovine oocytes derived from follicles of different sizes to
undergo normal fertilization and early embryonic development in vitro (Pavlok et al.,
1992).  Follicles were categorized into three groups: >4 to 8 mm (large), >2 to 4 mm
(medium) and >1 to 2 mm in diameter (small).  After IVF, embryonic development was
recorded and it was noted that there were significantly more embryos that cleaved from
oocytes recovered from large follicles (68.9%) compared with those recovered from
medium (64.3%) or small (19.7%) follicles.  Similarly, blastocyst development followed
the same pattern.  Significantly more embryos developed to the blastocyst stage after
oocytes had been recovered from large follicles (27.7%) than from medium (20.9%) or
small (0%) ones.  These results demonstrate the correlation between follicular size and
oocyte developmental competence.  It is apparent that oocytes obtained from small
bovine follicles do not have the same capacity to develop in vitro as do oocytes acquired
from larger follicles.
Lonergan et al. (1994) also investigated the effect of the size of bovine follicles
from which the oocytes originate on their subsequent in vitro developmental ability.
Follicles were categorized into two groups based on diameter: 2 to 6 mm (small) and >6
mm (large).  Cleavage rates were not different between the small (92.9%) and large
(90.8%) follicle groups.  However, blastocyst development was significantly lower for
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those oocytes retrieved from small follicles (34.3%) compared with oocytes recovered
from large follicles (65.9%).
In a study conducted on tamer wallaby oocytes, Mate and Rodgers (1993) studied
the effect of follicle size on oocyte meiotic competence.  Oocytes obtained from small
(<1.5 mm) and large (≥1.5 mm) follicles were placed into maturation medium.
Significantly more oocytes reached M-II from large follicles (55%) compared with
oocytes recovered from small follicles (20%).  This study clearly illustrated that a
relationship between follicle size and oocyte quality in terms of in vitro developmental
and meiotic capacity does exist, with oocytes originating from larger follicles being
superior to those originating from smaller tamer wallaby follicles.
Another factor, in addition to follicle size and quality, that affect IVM are serum
type, hormones and the addition of cumulus cells (Fukui et al., 1997).  Oocyte maturation
rates in the Minke whale significantly increased from 6.6% when oocytes were exposed
to only TCM-199 and fetal whale serum (FWS) to 21.6% when oocytes were exposed to
TCM-199 supplemented with fetal whale serum (FWS), LH, FSH and cumulus cells.
Oocyte Diameter
Another factor that can be correlated with follicular size and the outcome of IVF
is oocyte diameter.  The oocyte growth phase includes a series of modifications of cell
organelles.  These modifications are crucial for an oocyte to attain meiotic and
developmental competence.  Fair et al. (1995) identified a possible relationship between
the diameter of bovine oocytes and follicle size and RNA transcriptional activity.
Ovarian follicles were classified into five groups based on size:  ≥4 mm, >3 to <4 mm, >2
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to 3 mm, >1 to 2 mm and <1 mm.  A positive correlation was found between oocyte
diameter and follicle size.  It was noted that bovine oocytes achieve maximum size when
the follicle has developed to 3 mm and after that oocyte growth levels off.  Hendriksen et
al. (2000) also documented that oocytes acquire the capacity to develop into an embryo
following IVF at the follicular stage of 3 mm.  However, they require an additional “pre-
maturation” to express this competence.  Pre-maturation of oocytes occurs in vivo prior to
the LH surge whereas, in vitro, oocytes are exposed to medium which aids in the oocyte’s
ability to mature, to be fertilized and to develop into a viable embryo (Hendriksen et al.,
2000).  Oocyte diameter varied from 99 µm for oocytes recovered from antral follicles
<1 mm to 117 µm for oocytes from follicles reaching >4 mm in diameter.  Similar
findings in relation to oocyte diameter were reported by Suzuki et al. (1994).  However,
slightly different results were obtained from a study conducted by Motlik and Fulka
(1986).  They found that the mean oocyte diameter was ~110 to 113 µm for porcine
oocytes from  follicles <1 mm in size.
The ability of bovine oocytes of different sizes to mature in vitro has also been
investigated (Fair et al., 1995).  Oocytes were placed into four treatment groups based on
diameter: oocytes <100 µm, 100 to 110 µm, 110 to 120 µm and >120 µm in diameter.
Following IVM, a significantly larger number of oocytes were at M-II when oocyte
diameter was 110 to 120 µm and >120 µm when compared with oocytes having a
diameter of <100 µm and 100 to 110 µm.  More oocytes with a diameter of <100 µm
remained at the germinal vesicle (GV) stage of nuclear maturation.  It appeared that
bovine oocytes acquire the ability to complete nuclear maturation at a diameter of
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~110 µm.  This report is comparable to the results obtained by Fuhrer et al. (1989),
Hyttel et al. (1997) and Sirard et al. (1998), all of which concluded that oocytes gradually
acquire competence to undergo meiotic maturation and sustain embryonic development
after reaching a diameter between 110 and 120 µm.  The degree of RNA synthesis was
determined by culturing bovine oocytes in the presence of 3H-uridine for 45 minutes.
Autoradiographic labeling showed a greater degree of RNA synthesis in oocytes <100
µm and 100 to 110 µm in diameter when compared with oocytes ranging from 110 to 120
µm and > 120 µm.  These results indicated that oocytes of smaller diameter were
involved in RNA synthesis and were consequently still in the growth phase (Fair et al.,
1995).
Although bovine oocytes obtained from small follicles normally do not acquire
competence until later in follicular growth, Mermillod et al. (2000) found a pre-
maturation culture system that could be applied to these oocytes in vitro to reproduce the
last steps of oocyte differentiation that normally occur late in folliculogenesis.
Roscovitine is a known inhibitor of maturation promoting factor (MPF) kinase activity in
bovine oocytes.  The addition of 25 µM of roscovitine to the culture medium was found
to maintain bovine oocytes at the GV stage for a 24-hour period.  The inhibitory effects
of this substance were also found to be reversible after exposing oocytes to TCM-199 and
10 ng/ml of EGF.  Approximately 90% of the oocytes reached the M-II stage and further
developed to the blastocyst stage after being exposed to roscovitine and EGF compared
with control oocytes.  These findings may allow for the setup of a culture system
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specially designed for oocytes known to have low developmental competence, especially
those recovered from follicles smaller than 3 mm in diameter (Mermillod et al., 2000).
Oocyte Maturation
Maturation of oocytes can be divided into two different stages, nuclear maturation
and cytoplasmic maturation.  Nuclear maturation can be defined as the series of
physiologic events that reflect the modification of chromatin from the diplotene phase
(GV) to M-II.  Cytoplasmic maturation encompasses all of the changes in the distribution
and organization of specific organelles from the GV to the M-II stage.  Cytoplasmic
maturation is associated with the cellular changes that occur during nuclear maturation
such as mitochondria repositioning and cortical granule migration (Sirard, 2001).
Various hormonal and follicular aspects reported to enhance both nuclear and
cytoplasmic maturation in bovine oocytes are shown in Figure 2.1.  See Sirard and
Blondin (1996) for a review of oocyte maturation and IVF in cattle.
Meiotic Arrest
It has been estimated that there are >150,000 oocytes in the ovaries of a heifer at
birth.  The process of meiosis begins early in fetal life but is arrested shortly after birth at
the diplotene stage.  Oocytes will either degenerate through the process of atresia or
resume meiosis just prior to ovulation.  Normal meiosis is resumed in the adult following
the preovulatory surge of gonadotropins (Ayalon et al., 1972; Vermeiden and Zeilmaker,
1974; Tsafriri et al., 1976).
Since 1935, researchers began to investigate the spontaneous events that lead to
oocyte maturation.  Pincus and Enzmann (1935) were the first to report the spontaneous
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nature of nuclear maturation by mammalian oocytes recovered from antral follicles.
They hypothesized that follicular components supplied the oocyte with a substance that
directly inhibited nuclear maturation (Pincus and Enzmann, 1935).  The phenomenon of
spontaneous maturation was later reported in mouse, sheep, cow, pig, rhesus monkey and
human oocytes (Edwards, 1965).  Two mechanisms were suggested to affect meiotic
arrest: (1) follicular fluid was mediating the inhibitory action on meiotic resumption
(Jagiello et al., 1977; Meinecke and Meinecke-Tillmann, 1981) or (2) close contact of the
oocyte to follicular cells was needed for an inhibitory signal to be transferred (Colonna et
al., 1989; Racowsky and Baldwin, 1989).
Several researchers have observed gap junctions between cumulus cells and the
oocyte (Unwin and Zampigni, 1980; Loewenstein, 1987; Sutovsky et al., 1993).
Physiologically, the function of follicular gap junctions is to provide nutrition to and from
cells, electric coupling and the transport of messenger molecules from follicular cells to
the oocyte (Lawrence et al., 1978).  Transfer of ions and small molecules between the
oocyte and cumulus cells were found to be maximized just prior to gonadotropic
stimulation and decreased thereafter (Moor et al., 1980).  This finding led researchers to
believe that there was a disassociation of the oocyte-cumulus cell gap junctions that
would ultimately lead to meiotic resumption in oocytes, possibly induced by the
gonadotropin surge prior to ovulation (Linder et al., 1974).  The transmission of
inhibitory substances was thought to be involved with the gap junctions that connect the
cumulus cells to the oocyte (Albertini and Anderson, 1974; Gilula et al., 1978; Larsen
and Wert, 1988; Motta et al., 1994).
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Sirard and Bilodeau (1990) determined that granulosa cells produced a factor that
inhibited nuclear maturation in bovine oocytes cultured in vitro.  Other authors have
suggested that there is an LH-induced loss of gap junctions that triggers the resumption of
oocyte maturation by reducing the transport of meiosis inhibitory substances to the
germinal compartment of the follicle (Larsen et al., 1986; Racowsky and Baldwin, 1989;
Wert and Larson, 1990).  These findings led to the hypothesis that follicular somatic cells
inhibit nuclear maturation.
An inhibitory effect of follicular fluid on the spontaneous maturation of oocytes
was first described by Chang (1955) in the rabbit.  It was later found that follicular fluid
inhibited maturation of pig (Tsafriri et al., 1976), rat (Tsafriri et al., 1977, 1978), hamster
(Gwatkin and Andersen, 1976), sheep and human oocytes in vitro.  When the medium
was supplemented with LH, oocytes were able to resume meiosis.  This finding
confirmed the role of LH in the control of the resumption of meiosis in vivo.
Similarly, in the cow, follicular fluid decreased the percentage of oocytes that
were able to mature (Sirard et al., 1992).  Romero-Arredondo and Seidel (1994)
concluded that bFF collected at 0 and 4 hours following the LH surge inhibited
maturation of oocytes.  However, this inhibitory effect was absent in bFF collected at ≥8
hours after the LH surge, as indicated by increased cumulus expansion and meiotic
maturation compared with control oocytes.
Secretion of Inhibitory Substances
Other studies have identified several substances in follicular fluid that prevented
the resumption of meiosis in the oocyte.  Mullerian inhibiting substance, a by-product of
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granulosa cells, has been found to inhibit maturation of rat oocytes (Takahashi et al.,
1986).  Linoleic acid (18:2), the most abundant fatty acid found in follicular fluid, was
found to inhibit meiotic resumption of denuded bovine oocytes (Homa and Brown, 1992).
Furthermore, another substance, termed oocyte maturation inhibitor (OMI), has been
reported to suppress the maturation of rat and pig oocytes (Tsafriri et al., 1982).  The
original source of OMI was thought to be the granulosa cells; however, it was found that
both the theca interna and granulosa cells interacted to play a key role in maintaining
meiotic arrest in the bovine oocyte (Richard and Sirard, 1996a, 1996b).  Hillensjo et al.
(1979) found OMI inhibited the resumption of meiosis only in those oocytes cultured
within their intact cumuli, but failed to affect the maturation of denuded pig oocytes.
This indicated that the inhibitory signal of OMI is communicated to the oocyte through
the interactions of the cumulus cells (Tsafriri et al., 1982).
Hypoxanthine, a purine commonly found in follicular fluid, has been shown to
exert negative effects on oocyte maturation.  In the mouse, hypoxanthine has been
reported to arrest oocytes for a prolonged period of time (Downs et al., 1985, 1989).
Kadam and Koide (1990) found that the concentration of hypoxanthine in bFF was able
to inhibit maturation of mouse oocytes in vitro.  They hypothesized that hypoxanthine
may not be the only substance in follicular fluid that maintained meiotic arrest in mouse
oocytes, but rather one of several factors.
Inhibin, a glycoprotein hormone, is synthesized by the granulosa cells of ovarian
follicles and accumulates in the follicular fluid (Erickson and Hssueh, 1978; Henderson
and Franchimont, 1983).  The major function of inhibin is to suppress the release of FSH,
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thereby negatively affecting follicular growth.  W.-S. et al. (1989) reported that rat
oocytes were prevented from maturing when exposed to inhibin.  In addition to OMI,
hypoxanthine and inhibin, 20β-dihydroxyprogesterone was also identified as being a
meiotic inhibitor of mouse oocytes (Barrett and Powers, 1993).
Although there may be numerous factors involved in oocyte maturation, it is
believed that the most prominent feature of the agents inducing oocyte maturation in vitro
is their ability to stimulate the production of cAMP (Sirard, 1990).  The cAMP pathway
involves the activation of protein kinase A, which phosphorylates proteins within the
oocyte that maintain meiotic arrest (Schultz, 1988).  Protein kinase A is part of a signal
transduction pathway that utilizes adenylate cyclase to convert ATP into cAMP.  This
process is under control of G-proteins (Mochly-Rosen, 1995).
When mouse and rat oocytes were cultured in the presence of cAMP derivatives,
spontaneous maturation was prevented (Cho et al., 1974; Nekola and Moore-Smith,
1975; Wassarman et al., 1976; Dekel and Beers, 1978; Downs and Eppig, 1984).
Similarly, maturation of amphibian oocytes is induced by an increase in P4 along with a
decrease in cAMP (Morrill et al., 1977; Speaker and Butcher, 1977; Schorderet-Slatkine
et al., 1978; Maller et al., 1979).  In contrast, cAMP increases in sheep oocytes before
resumption of meiosis (Moor et al., 1981).  However, it has been suggested that cAMP
may serve as the physiological inhibitor of meiosis, which is transmitted from the
cumulus cells of the follicle through distinct gap junctions.
Consequently, cAMP has been proposed to be the inhibitory signal that maintains
bovine oocytes in the GV stage of nuclear maturation (Eppig and Downs, 1984; Homa,
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1988; Eppig, 1991; Bilodeau et al., 1993; Richard et al., 1997).  A decrease in cAMP
levels within the oocyte appears to be the initial step in the cascade of events ensuring
oocyte maturation (Aktas et al., 1995).  Other substances, such as hypoxanthine and
adenosine act synergistically to help maintain increased cAMP concentrations, thus
promoting meiotic arrest.
To further prove the inhibitory role of cAMP in resumption of meiosis,
researchers have studied the effects of certain chemicals that elevate intracellular levels
of cAMP such as dibutyryl cAMP, forskolin, cholera toxin, sodium fluoride,
prostaglandin E2, 6-dimethylaminopurine and cycloheximide.  Increased levels of these
chemicals ultimately leads to inhibition of nuclear maturation in bovine oocytes due to
their ability to increase cAMP levels within the oocyte (Sirard and First, 1988; Sirard,
1990; Bilodeau et al., 1993; Aktas et al., 1995).
Resumption of Meiosis
Resumption of meiosis in bovine oocytes (see Sirard et al., 1998 for review)
requires the synthesis of certain proteins at the onset of maturation (Simon et al., 1989;
Sirard et al., 1989; Tatemoto and Terada, 1995).  During the first hours of culture,
proteins that aid in nuclear envelope breakdown are synthesized.  Thereafter, bovine
oocytes continue to require protein synthesis throughout the entire process of maturation
(Kastrop et al., 1991; Milovanov and Sirard, 1994).  Protein synthesis of the oocyte to
resume meiosis has been correlated to the amplification of MPF, along with the synthesis
of cyclin B, an integral component of MPF activity.
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Downs (1993) reviewed the factors affecting resumption of meiosis in
mammalian oocytes.  There have been two proposed hypotheses for the mechanism
involved in meiotic maturation: (1) a loss of inhibitory input and (2) positive stimulation.
After the preovulatory gonadotropin surge, gap junctions become disrupted, allowing for
a loss of communication between follicular cells and the oocyte.  This ultimately
interrupts the flow of inhibitory substances such as cAMP to the oocyte and indirectly
promotes the onset of maturation (Dekel et al., 1988; De Loos et al., 1994; Hyttel, 1997).
The second hypothesis suggests there is a positive factor that acts on the oocyte to
override the inhibitory influence, thereby inducing the onset of germinal vesicle
breakdown.  Calcium has been identified as a possible candidate due to research reporting
spontaneous maturation of oocytes following exposure to calcium ionophore, A23187
(Powers and Paleos, 1982; Racowsky, 1986).
When resumption of meiosis finally occurs, it is regulated by a considerable
increase in the cytosolic kinase activity of the oocyte.  Researchers have shown that MPF,
comprised of the p34cdc2 kinase and cyclin B, is a crucial component of this activity
(Dekel, 1996; Levesque and Sirard, 1996; Whitaker, 1996).  Downs (1995) identified
MPF as a serine-threonine protein kinase that is involved in regulation of the cell cycle.
It is also know that MPF increases after germinal vesicle breakdown, with a decline in
MPF when the first polar body is extruded.
Effects of Follicular Fluid
Given that resumption of meiosis and cytoplasmic maturation of oocytes takes
place in close association with follicular fluid, supplementing media with follicular fluid
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would be a logical choice for researchers.  Many researchers have looked at the effects of
supplementing maturation media with follicular fluid on subsequent maturation and
embryonic development.  Chauhan et al. (1997) replaced serum and hormone additives
with follicular fluid in the IVM medium to look at the effects on maturation, fertilization
and embryonic development of buffalo oocytes.  Follicular fluid was collected from all
visible follicles and then pooled.  Nuclear maturation rates were similar between oocytes
placed into TCM-199 + 10% FBS + 5 µg/ml pFSH (74%), TCM-199 + 20% follicular
fluid (FF) (67%) and TCM-199 + 40% FF (67%), but these were significantly higher than
those oocytes matured in TCM-199 + 10% FBS (47%).  There was also a greater degree
of cumulus expansion in those oocytes matured with 20% or 40% FF although cleavage,
morulae and blastocyst rates did not differ.  Results from this study suggested that buffalo
follicular fluid had substances present, which promoted both nuclear and cytoplasmic
maturation, therefore indicating its potential as a possible supplement for IVM medium.
Comparable results were obtained when follicular fluid from large bovine follicles
(≥15 mm) was added to maturation medium (Elmileik et al., 1995).  Follicular fluid had
no direct stimulatory effects on the rate of nuclear maturation. However, the addition of
10% to 15% bFF to the maturation medium resulted in significantly higher rates of
morula, blastocysts and hatched blastocysts compared with the controls.  The authors
concluded that follicular fluid from follicles ≥15 mm in diameter contained stimulatory
agents that during IVM promoted the developmental potential of the oocytes to develop
into viable embryos.
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Similar results were obtained by Kim et al. (1996) when using follicular fluid
collected from small follicles (<5 mm) as a supplement to the maturation medium.
Medium supplemented with 10% or 30% FF did not affect the oocytes development to
the blastocyst stage, whereas 60% FF significantly decreased embryonic development.
Also, there were no differences detected when analyzing the total number of cells present
from day-9 blastocysts.  These results suggest that by supplementing bFF from small
follicles to IVM medium, one would be able to promote normal embryonic development
(Kim et al., 1996).
Romero-Arredondo and Seidel (1996) also noted normal embryonic development
followed by maturing bovine oocytes in 10% or 40% FF for 20 hours.  A slightly
different trend was noticed by Choi et al. (1998) when they compared IVM rates of
bovine oocytes matured in medium supplemented with follicular fluid collected from
large (10 to 20 mm) or small (2 to 5 mm) follicles.  Maturation medium consisted of
TCM-199 supplemented with 1 IU ml-1 of eCG and follicular fluid from either large or
small follicles.  It should be noted that maturation was conducted in co-culture with
bovine oviductal epithelial cells.
Significantly more oocytes matured in the medium supplemented with bFF from
small (77.9%) compared with large follicles (69%).  However, significantly more oocytes
underwent maturation (91.7%) when no bFF was added to the maturation medium.  No
differences were noted with the total number of oocytes that became fertilized between
treatments, although bFF from large follicles decreased the rate of male pronucleus
formation.  There were a greater number of embryos that developed to the blastocyst
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stage when bFF from small follicles (15.4%) was utilized compared with bFF from the
large follicles (5.3%).  However, blastocyst rates were significantly lower from those
oocytes matured in follicular fluid recovered from both large and small follicles when
compared with the controls (31.8%).  These findings indicate that the developmental
capacity of bovine oocytes to mature in follicular fluid is dependent on the developmental
stage of the follicles from which the fluid was collected (Choi et al., 1998).
Although contradictory results were previously reported by Elmileik et al. (1995),
the total concentration of FF added to the medium could have played a factor with the
deceased rates observed by Choi et al. (1998).  Decreased maturation rates were also
noted by Ayoub and Hunter (1993) when bovine follicular fluid was added to the
maturation medium.  Follicular fluid collected from small follicles (2 to 4 mm) was only
able to promote nuclear maturation in 1.4% of the total number of oocytes.  Follicular
fluid from medium-sized follicles (5 to 9 mm) promoted maturation in 1.3% of oocytes
whereas, fluid collected from large follicles led to maturation of 2.7% of oocytes
cultured.  These results were significantly lower than in medium containing only TCM-
199 (46.2%).  Therefore, bFF aspirated from small, medium and large follicles was able
to inhibit germinal vesicle breakdown, ultimately leading to poor embryo production
(Ayoub and Hunter, 1993).
Other types of supplements, such as estrous cow serum (ECS), FBS and bovine
amniotic fluid (bAF) were tested in addition to bFF to determine their effects on nuclear
maturation rates (Quero et al., 1994).  Preovulatory follicles were aspirated and oocytes
were cultured in TCM-199 containing 20% of one of the previously mentioned protein
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supplements for 24 hours.  The percentage of mature oocytes was significantly higher in
media supplemented with ECS (78%), FBS (79%) and bAF (77%) compared with bFF
(52%).  Although bFF did not yield high maturation rates, it was concluded that bovine
maturation medium could be supplemented with other compounds to yield acceptable
maturation rates.
Porcine follicular fluid (pFF) has also been used in maturation media to determine
its effect on the ability of bovine oocytes to mature.  When bovine oocytes were matured
in pFF (collected from 3 to 5 mm follicles), 70% of oocytes matured compared with 75%
matured in bFF (aspirated from 2 to 5 mm follicles) and 76% in TCM-199 alone.  This
report illustrated that certain nuclear maturation inhibitory factors found in pFF may not
be exhibiting such effects on the bovine oocyte (Leibfried and First, 1980).  However,
when pFF was used as a supplement to mature porcine oocytes in vitro, two distinct
effects were found.  It was shown that pFF inhibited nuclear maturation, but it enhanced
cytoplasmic maturation as indicated by pronuclear formation (Gallardo et al., 2001).
Although there are contradictory reports on the beneficial/detrimental effects of
FF on nuclear maturation, Bogh et al. (2002) determined that equine follicular fluid (eFF)
was beneficial when added to maturation medium.  They found that (1) equine oocytes
could be matured in vitro using pure equine preovulatory follicular fluid, (2) preovulatory
follicular fluid collected after gonadotropin-priming was superior for supporting nuclear
maturation than standard culture media and (3) equine oocytes aspirated 8 days after a
previous aspiration were less likely to mature than those aspirated during the initial
collection.
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It is evident from previous research that in vitro oocyte maturation is dependent
on several factors including stage of the estrous cycle, concentration of follicular fluid,
the time oocytes remain in culture, various levels of inhibitory substances and the size of
follicles from which the fluid is collected.
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CHAPTER III
EFFECT OF HOLDING BOVINE OOCYTES IN FOLLICULAR FLUID FOR
12 HOURS AT 38ºC ON OOCYTE NUCLEAR MATURATION
Introduction
Pincus and Enzmann (1935) first reported the spontaneous nature of oocyte
maturation in the rabbit following removal from the follicular environment.  This original
observation has since been confirmed in other mammals, leading to the general
acceptance of the hypothesis that meiotic arrest in mammalian oocytes is maintained by
an array of factors existing within the microenvironment of the follicle (Cho et al., 1974;
Thibault et al., 1987; Bilodeau et al., 1993; De Loos et al., 1994; Aktas et al., 1995).
Primary factors that have been identified include cAMP (Downs and Eppig, 1984),
hypoxanthine (Downs and Eppig, 1984), E2 (Racowsky, 1985) and OMI (Tsafriri and
Pomerantz, 1986).  Two hypotheses have been made as to how these inhibitory
substances become transmitted to the oocyte proper.  First, granulosa cells are believed to
secrete “arrestors” into the extracellular follicular fluid, which is either taken up directly
by the oolemma and/or indirectly through the adjacent cumulus cells (Eppig and Downs,
1984).  The second is that the “arrestor” is transmitted through the abundance of gap
junctions known to connect both the theca and granulosa cells of the oocyte (Albertini
and Anderson, 1974).
These findings become relevant when attempting to determine the effect of
follicular fluid on oocyte maturation.  Follicular fluid has been shown to be a beneficial
supplement in the maturation media of the pig (Naito et al., 1988; Gallardo et al., 2001),
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sheep (Sun et al., 1994), cow (Romero-Arredondo and Seidel, 1994; Elmileik et al.,
1995; Kim et al., 1996; Choi et al., 1998; Avery et al., 2003), horse (Dell’ Aquila et al.,
1997; Bogh et al., 2002; Hinrichs et al., 2002) and buffalo (Chauhan et al., 1997).
However, follicular size and concentration of follicular fluid have been found to be
important contributors to the success rates of oocyte maturation (Tan and Lu, 1990;
Pavlok et al., 1992; Blondin and Sirard, 1994; Fouladi Nashta et al., 1998).
Utilizing follicular fluid as a holding medium for in-the-field purposes could
prove to be an easy and efficient way to rescue valuable genetics from deceased females.
After aspirating ovarian follicles in the field and dispensing the contents into tubes,
follicular fluid could be used as a holding medium until oocytes could be recovered and
IVF could be performed in a laboratory where there is essential equipment and
experienced personnel.  The practical considerations of this approach could prove to be
beneficial in the event of the untimely death of a genetically superior animal.  Schroeder
et al. (1991) demonstrated that mouse oocytes were able to mature, to be fertilized and to
develop into viable embryos following a 12-hour holding period following the death of
the animal.
The objective of Experiment 1 was to determine the effect of bFF as a holding
medium on oocyte maturation.  The effect of follicular fluid was analyzed with the hopes
of being able to use this medium as a potential environment in which oocytes could be
held for a prolonged period of time until assisted reproductive techniques could be




To obtain good oocyte quality, a commercial abattoir (Hydes, Robert, LA) was
contacted the morning of ovary collection.  This ensured a specific window of time in
which the ovaries were stored before oocyte retrieval.  Ovaries were harvested from
various culled female cattle of various ages, weights and reproductive stages.
Immediately following slaughter, ovaries were placed into a previously prepared Ovary
Transport Medium (Appendix A).  Upon arrival of the technician at the abattoir, the pool
of ovaries were then rinsed with fresh Ovary Transport Medium and wiped with ethanol-
soaked gauze pads (4 x 4, Johnson and JohnsonTM, Arlington, TX) to remove blood and
debris from the ovaries.  The harvested ovaries were then placed into a Ziploc® plastic
bag containing 500 ml of fresh Ovary Transport Medium.  The ovaries were then
transported ~100 km back to Louisiana State University Embryo Biotechnology
Laboratory in a styrofoam container maintained at room temperature (~22ºC).  The time
from collection of the first set of ovaries to their arrival at the laboratory was ~6 hours.
Collection of Oocytes
Upon arrival at the laboratory, ovaries were again rinsed with fresh Ovary
Transport Medium and cleansed with ethanol-soaked gauze pads.  The follicle
development pattern was recorded and the presence of a dominant follicle and luteal
tissue were noted.  Ovaries with no follicular development were excluded from the study.
Follicles ranging in diameter from 2 to 9 mm were aspirated using a 20-gauge, 37.5-mm
needle (Kendall, Mansfield, MA) attached to a 12-ml disposable syringe (Sherwood
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Davis and Geck, St. Louis, MO).  The follicular aspirate from each ovary group was
pooled and placed directly into sterile 15-ml plastic conical tubes (Corning, New York,
NY).
Experimental Design
Ovaries were randomly allotted into one of two treatment groups before oocyte
aspiration.  Ovaries randomly assigned to Treatment A (Control Stain), which served as a
control, were immediately aspirated and the recovered oocytes were denuded and stained
to determine nuclear status.  Ovaries allotted to Treatment B (Follicular Fluid) were
aspirated and the pooled follicular fluid was dispensed into a 15-ml plastic conical tube.
The tube was then placed into an incubator at 38ºC with 5% CO2 in air for 12 hours.
Following the allotted time period, oocytes were denuded, stained and the nuclear status
was recorded.
Nuclear Staining Procedure
The follicular aspirate from the two treatment groups was dispensed into 100 x
15-mm Falcon® square-style search dishes (Beckton Dickinson, Lincoln Park, NJ).  Using
a Nikon SMZ-2B stereoscopic microscope (Nikon, Tokyo, Japan), oocytes were
recovered and then washed twice through 35 x 10-mm Falcon® plastic petri dishes
(Becton and Dickinson, Lincoln Park, NJ) containing warm Oocyte Holding Medium
(Appendix B) using a hand pulled 225 mm Pasteur pipette (Fisher ScientificTM,
Pittsburgh, PA), with an inside diameter of 100 to 150 µm.  After washing the oocytes,
they were placed into a 15-ml plastic conical tube containing Oocyte Denuding Medium
(Appendix C).  The conical tube was then placed into the incubator equilibrated at 38.5ºC
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for 3 minutes to allow the cumulus cells to expand before vortexing.  The tube was then
vortexed for 3 minutes (Vortex Genie).
Following vortexing, 5-ml of Oocyte Holding Medium was placed into the
conical tube to properly wash oocytes from the sides of the tube.  After allowing 3
minutes for the oocytes to settle to the bottom of the tube, the supernatant was removed
and the pellet was aspirated and placed into 500-µl of Oocyte Staining Medium
(Appendix D) previously added to a four-well dish (NUNCTM, Denmark).  Oocytes were
labeled with 1 to 5 µl/ml of nuclear stain, bis-benzimide, and held in the third well for 5
minutes while in the incubator at 38.5ºC.  Correspondingly, a 60 x 15-mm petri dish
(Falcon®, Becton Dickinson, Lincoln Park, NJ) was prepared by adding a 60-µl droplet of
Oocyte Holding Medium at the top followed by a 180-µl droplet of Oocyte Holding
Medium in the center of the dish.  After the allotted time period, oocytes were removed
from the bis-benzimide stain and transferred into the 180-µl droplet overlaid with warm
embryo-tested mineral oil (M-8410, Sigma Chemical Co., St. Louis, MO).  The petri dish
was then placed on the stage of an inverted microscope (Nikon Diaphot, Tokyo, Japan)
equipped with Narishige micromanipulators, epifluorescent illumination and Hoffman
Modulation Contrast objectives.
Holding pipettes were hand-forged from borosilicate glass tubing (1.0 mm outside
diameter) using a Sutter Micropipette Puller (Sutter Instrument Co., Novato, CA) in
combination with a Narishige Microforge and Narishige Microgrinder (Narishige
Scientific Instrument, Tokyo, Japan).  Holding pipettes were pulled to an outside
diameter of 75 µm and then fire polished to create a 35-µm inner diameter.  Using the
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holding pipette to stabilize the oocyte, the nucleus was rotated into focus using an
enucleation pipette while under exposure to UV-light.  Individual oocytes were examined
and their nuclear status was recorded.
Oocytes were classified as being either at the GV, GVBD, M-I or M-II stage of
nuclear maturation.  Oocyte quality was also recorded based on the percent of viable
oocytes following treatment.  A representative viable oocyte from the Control Stain
(Treatment A) group is shown in Figure 3.1.  Figure 3.2 illustrates non-viable oocytes
following exposure to the Follicular Fluid (Treatment B) group.
Statistical Analysis
Data for this experiment were analyzed using the Frequency Procedure (Chi
square) (SAS, 1992).  The main effects and differences between treatments were
considered significant at the P<0.05 level.  The total number of oocytes at each stage of
nuclear maturation was used as the endpoint for treatment comparison.
Results
The number of oocytes and percentages identified as being in the different phases
of nuclear maturation are summarized in Table 3.1.  There were a total of 30 ovaries
aspirated per treatment group in this experiment.  Of the total of 76 oocytes in the Control
Stain group (Treatment A), 49% of them were identified as being at the GV stage
following nuclear staining.  In the Follicular Fluid group (Treatment B), 32% of the total
of 112 oocytes were determined to be at the GV stage of nuclear maturation.  There was
no significant difference (P>0.05) between the number of oocytes identified at the GV
stage in the Control Stain (Treatment A) and Follicular Fluid
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Figure 3.1. A representative viable bovine oocyte from the Control Stain
(Treatment A) group.
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Figure 3.2. Non-viable bovine oocytes following exposure to the Follicular Fluid
(Treatment B) group.
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* A = Control Stain, B = Follicular Fluid.
ŧ GV = percentage of oocytes maintained at the germinal vesicle stage, GVBD =
   percentage of oocytes found to be at the germinal vesicle breakdown stage, M-I =
   percentage of oocytes that progressed to metaphase I and M-II = percentage of nuclear
   mature oocytes, % viable = those oocytes with an intact oolemma and cytoplasm at
   the time of nuclear status determination.
a,bColumns with different superscripts are significantly different (P<0.05) (Chi square).









76 (100)a   76 38 (49)a 18 (23)a 20 (26)a  0 (0)a    A (Control Stain) 30
    112 36 (32)a 39 (35)a 32 (29)a  2 (2)a 0  (0)b30   B (Follicular Fluid)
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(Treatment B) groups.  Furthermore, the number of oocytes determined to be at the
GVBD stage in Treatments A and B were not significantly different (P>0.05).  The
percentage of oocytes at the GVBD stage of nuclear maturation for Treatments A and B
was 23% and 35%, respectively.
Similarly, the number of oocytes classified as M-I were not significantly different
(P>0.05) between Treatment A (26%) and Treatment B (29%).  In addition, the
percentage of nuclear-mature (M-II) oocytes for Treatment A and Treatment B was 0%
and 2%, respectively.  There was no statistical difference (P>0.05) detected for the total
number of nuclear mature-oocytes between treatment groups.  However, there was a
negative effect of follicular fluid (Treatment B) on the percent of viable oocytes
following a 12-hour incubation period.  Oocytes in Treatment B were clearly
compromised, having a grainy appearing cytoplasm and often a ruptured oolemma.
Discussion
The number of bovine oocytes identified as being either at the GV, GVBD, M-I
and M-II stages of nuclear maturation in the Follicular Fluid group (Treatment B) were
markedly less than those treated with follicular fluid as reported by Avery et al. (2003).
In the latter study, bovine oocytes were held in in vitro maturation medium consisting of
either follicular fluid collected from a pool of 3 to 15 mm follicles (FF), pre-ovulatory
follicles (POF), follicular fluid from heifers synchronized with a CIDR followed by
PGF2α and then oocytes were recovered using the transvaginal ultrasound-guided
aspiration (TUGA) approach or TCM-199 supplemented with 5% FBS.  The percent of
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oocytes reaching the M-II stage was only 41% for the FF group compared with 69% from
POF, 72% from TUGA and 69% from the TCM-199 group.
One possible explanation for the difference reported in maturation rates of bovine
oocytes by Avery et al. (2003) could be that cumulus cells were removed from the
follicular fluid by centrifugation, whereas in our study, the undiluted follicular fluid was
used immediately following recovery, without any further treatment.  It is possible that
the cumulus cells secreted inhibitory substances, such as oocyte maturation inhibitor
(OMI), hypoxanthine and cyclic adenosine monophosphate (cAMP) to ensure meiotic
arrest of the oocyte before the onset of autolysis.  These inhibitory substances likely
remained in the follicular fluid for the 12-hour holding interval.  In addition, holding
these oocytes in follicular fluid for 12 hours at 38°C was detrimental to the oocytes
ability to mature.  Lenz et al. (1983) reported the optimal temperature for bovine oocyte
maturation ranged between 35°C and 39°C.  This temperature has been established for
various IVM and in vitro culture media.  However, incubating follicular fluid (comprised
of numerous granulosa cells) within the range reported by Lenz et al. (1983) was
detrimental to the oocytes and their ability to survive.
Kotsuji et al. (1994) reported that 100% of bovine oocytes matured when cultured
with granulosa cells alone.  However, when a combination of both granulosa and theca
cells was used in the culture medium, GVBD was delayed for up to 12 hours.  One can
only speculate that one of the reasons that oocytes held in follicular fluid prior to
maturation in our study did not mature was likely due to the combination of both
follicular cell types in the fluid used to hold the oocytes.
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Other factors contributing to the extremely low maturation rate found in our study
in Treatment B could be the temperature at which the undiluted follicular fluid was held
at prior to use, another being the affect of temperature on the cumulus cells in the
follicular fluid and their ability to undergo rapid autolysis, secreting detrimental
substances in the medium.  Another possible factor could be the amount of time at which
the oocytes remained in the fluid.  A 12-hour time interval was detrimental to the oocytes
as indicated by damage to the oolemma and a disrupted appearance to the cytoplasm.
The percentage of viable oocytes following treatment was not comparable between
Treatment A (100%) and Treatment B (0%).  The detrimental effects of placing oocytes
directly into pooled follicular fluid at 38ºC for a 12-hour time period was dramatic (100%
vs. 0%).  The reason for these results remains unclear.
The ability to utilize bovine follicular fluid as a holding medium before IVM and
subsequent fertilization would be beneficial for in-field purposes; however, the results
from this experiment do not indicate it would be feasible to use this approach.  Further
research is needed to determine the reason(s) that follicular fluid exhibited a detrimental
effect on bovine oocytes during a 12-hour holding period at 38°C.
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CHAPTER IV
EFFECT OF HOLDING BOVINE OOCYTES IN FOLLICULAR FLUID FOR 12
HOURS AT 22ºC ON SUBSEQUENT EMBRYONIC DEVELOPMENT
Introduction
Although the specific function of follicular fluid is still unclear, it has been
speculated that follicular fluid could protect the oocyte from factors that could induce the
premature resumption of meiosis (Espey and Lipner, 1994), assist with oocyte expulsion
during the ovulatory process (Rodriguez et al., 2001), enhance sperm cell attraction to the
oocyte in addition to sperm motility and the acrosome reaction (Wang et al., 2001).
One area of research has included follicular fluid as a supplement to maturation
medium to determine its effect on meiotic resumption.  The addition of follicular fluid to
maturation medium has been used as a substitute for serum for IVP in rabbit (Kane and
Headon, 1980), caprine (Guler et al., 2000), equine (Dell’Aquila et al., 1997), bovine
(Leibfried et al., 1986; Kim et al., 1990; Khatir et al., 1997), porcine (Yoon et al., 2000)
and human (Chi et al., 1998) species.  An overall conclusion was reported from each of
the above studies, although findings were generally contradictory.  Consistent
observations include the rates of oocyte maturation in follicular fluid were dependent on
the stage of the estrous and menstrual cycles and the concentration of follicular fluid
supplemented to the maturation medium.
Hinrichs et al. (2002) reported an increase in the maturation rate of equine
oocytes to 24% when 100% equine follicular fluid was used in the maturation medium
rather than the 12% maturation rate when 20% follicular fluid was used in their study.
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Similarly, Bogh et al. (2002) found that a greater number of equine oocytes exposed to
preovulatory follicular fluid during the maturation process were able to mature compared
with that of control oocytes that were not exposed to follicular fluid during maturation.
Follicular fluid has also been shown to be beneficial in terms of blastocyst
production.  Elmileik et al. (1995) reported an increase in bovine blastocyst rates when
maturation medium was supplemented with 10% follicular fluid (36%) compared with
medium containing no follicular fluid supplementation (27%).
Higher maturation rates were observed for bovine oocytes cultured in follicular
fluid obtained from large follicles compared with medium and small follicles (Romero-
Arredondo and Seidel, 1994).  Also, embryonic development to the blastocyst stage was
achievable when supplementing follicular fluid in the maturation medium.  However,
follicular fluid was not superior to serum supplementation during the maturation process.
Even though bFF has been shown to contain various inhibitors of meiotic
resumption (Eppig and Downs, 1984; Sirard and First, 1988; Gosden et al., 1990; Kadam
and Koide, 1990; Sirard, 1990; Sirard and Bilodeau, 1990; Ayoub and Hunter, 1993;
Downs, 1993), follicular fluid could still prove to be a beneficial medium to temporarily
hold harvested oocytes for a short period of time.  For example, a producer might
discover that one of his highest producing dairy cows had unexpectedly died.  In this
situation, the producer might be able to remove the ovaries and aspirate the follicles,
dispense the fluid into a tube and transport the contents to a veterinary clinic where the
oocytes could be recovered for IVF.  Depending on the location of the laboratory, oocytes
may remain in this undiluted fluid for an extended period of time.  Therefore, it would be
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imperative to determine the optimal time these oocytes could be held before embryonic
developmental rates begin to decline.
The objective of Experiment 2 was to examine the effect of follicular fluid on the
in vitro developmental potential of bovine oocytes recovered from abattoir-derived
ovaries.  The specific objective was to determine the feasibility of holding bovine oocytes
in undiluted follicular fluid for a 12-hour time interval at room temperature (22°C).
Materials and Methods
Ovary Collection
To ensure that ovaries were not contaminated on the morning of collection, the
abattoir (Hydes, Robert, LA) was notified as to the time at which the ovaries would be
obtained for experimental use.  The abattoir primarily slaughters dairy-type cows usually
consisting of Holstein and Jersey breeds, although various beef breeds are occasionally
processed.  The weight, age and stage of reproductive cycle of the females varied
depending on the particular day of the week the ovary collections were made.  However,
the day of the week was selected based on when mature, cycling cows were being
slaughtered, to assure the ovaries of immature heifers would not be used in the
experiment.  Upon arrival of the technician to the abattoir, ovaries were obtained from the
plastic storage container, which had previously been filled with Ovary Transport Medium
consisting of sterile physiological saline supplemented with antibiotics (Appendix A).
The harvested ovaries were subjected to cleansing with an additional 500 ml of
fresh Ovary Transport Medium, followed by wiping them three times with ethanol-
soaked gauze pads (4 x 4, Johnson and JohnsonTM, Arlington, TX).  The ovaries were
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then transferred to a clean Ziploc® plastic bag containing fresh Ovary Transport Medium
where they were stored at ~22°C until arrival at the laboratory.  Transport time for the
ovaries in this experiment ranged from 6 to 8 hours.  Ovary transport time was calculated
as the time from the collection of the first pair of ovaries to the time they arrived at the
laboratory.
Oocyte Collection
Once at the laboratory, the ovaries were again rinsed with fresh Ovary Transport
Medium and placed on a sterile drape.  The ovaries were wiped one additional time with
ethanol-soaked gauze pads to prevent contamination.  The ovaries were then examined
for structures that would indicate the stage of their reproductive cycle.  Preovulatory
follicles were identified along with the presence of any CH’s, CL’s and CA’s.  Follicle
populations were evaluated before randomly allocating the ovaries to their respective
treatment groups.  All follicles ranging from 2 to 9 mm in diameter were aspirated using
a 20-gauge, 37.5-mm needle (Kendall, Manfield, MA) attached to a 12-ml disposable
syringe (Sherwood Davis and Geck, St. Louis, MO).  Throughout the procedure, ovaries
were continuously wiped with ethanol-soaked gauze pads to reduce possible
contamination.  Once all usable follicles were punctured, the aspirates were pooled and
placed into separate sterile 15-ml plastic conical tubes (Corning, New York, NY) that
were labeled with the appropriate treatment group, the date and the aspiration time.
Experimental Design
Individual ovaries were distributed into either one of two treatment groups
completely at random.  Treatment A (Control IVF) served as the control.  Ovaries
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assigned to this group were aspirated and follicular fluid was pooled and placed into a 15-
ml plastic conical tube.  The aspirate was searched and placed into IVM for 22 hours
followed by performing IVF.  The ovaries allotted to Treatment B (Follicular Fluid) were
aspirated, followed by pooling of the follicular fluid and dispensing it into a separate 15-
ml plastic conical tube.  The conical tube was properly labeled with the time, the date, the
treatment group and wrapped in aluminum foil to avoid light exposure.  The conical tube
was held at 22ºC for a 12-hour period.  The follicular aspirate was then searched and the
oocytes were placed into a standard laboratory Maturation Medium (Appendix E)
followed by IVF.
IVM
Following follicle aspiration, the aspirate from Treatment A was immediately
dispensed into 100 x 15-mm Falcon® square style search dishes (Becton Dickinson,
Lincoln Park, NJ).  The 15-ml conical tube was rinsed with 2 ml of pre-equilibrated
Maturation Medium to ensure all oocytes became dislodged from the bottom and sides of
the tube.  A stereoscopic microscope (Nikon SMZ-2B, Tokyo, Japan) was used to
identify oocytes after which they were transferred into a 35 x 10-mm Falcon® plastic petri
dish (Becton and Dickinson, Lincoln Park, NJ) containing 2 ml of pre-warmed
Maturation Medium using a 225-mm Pasteur pipette (Fisher ScientificTM, Pittsburgh,
PA).
Oocytes were washed twice with Maturation Medium before being placed into the
final maturation droplets.  Then 10 to 15 oocytes were randomly placed into each 50-µl
droplet.  Once all recovered oocytes were thoroughly washed and placed into maturation
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droplets, the dish was placed into a 38ºC and 5% CO2 in air humidified incubator for 22
hours.
After the follicular aspirate had been held for 12 hours in Treatment B (Follicular
Fluid), the contents of the tube were dispensed into a 100 x 15-mm Falcon® square style
search dish.  To loosen the pellet of cumulus cells, 2 ml of Maturation Medium were
added to the tube.  Recovered oocytes were placed into a 35 x 10-mm Falcon® plastic
petri dish containing 2 ml of Maturation Medium, washed twice and placed into 50-µl
droplets of Maturation Medium covered with embryo-tested mineral oil (M-8410, Sigma
Chemical Co., St. Louis, MO).  The oocytes were allowed to mature for 22 hours at 38ºC
and 5% CO2 in air for 22 hours.
Media Preparation for IVF
Before oocytes were removed from the Maturation Medium, IVF stock media
were prepared.  Brackett-Oliphant (BO) stocks were first prepared followed by CR1aa
Stock Medium as described by Rosenkrans and First (1994) (Appendices F, G and H).
Then, Fertilization Medium, BO-Caffeine Medium, BSA-BO (0.6%) Medium and BSA-
BO (0.3%) Medium were prepared (Appendices I, J, K and L).
Semen Preparation
After allowing for proper equilibration times, the semen was prepared for IVF.
First, an empty 35 x 10-mm FalconTM plastic petri dish was placed into the incubator
labeled with the appropriate treatment group, the time and the date to avoid temperature
shock to the spermatozoa.  Then, a 40º C to 41ºC water bath was prepared for the semen
thawing process.
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Semen was obtained from a fertile Holstein bull (CSS 7H5188, Genex
Cooperative Inc., Shawano, WI).  Semen from a single bull was used for IVF in all
experiments.  Once the appropriate straw of frozen semen was located, it was removed
from liquid nitrogen and dropped immediately into the water bath for 45 seconds.  After
being thawed, the contents of the straw were dispensed into a sterile 15-ml plastic conical
tube.  A total of 9 ml of pre-equilibrated BO-Caffeine Medium was added to the semen.
The tube was centrifuged for 6 minutes at 200 x g.  The supernatant was removed, being
careful to not disturb the pellet of sperm cells remaining at the bottom of the tube.  An
additional 9 ml of BO-Caffeine Medium was added to the tube and the pellet was
resuspended.  The sperm cells were then exposed to 6 more minutes of centrifugation at
200 x g.  The supernatant was again removed, followed by adding 4 ml of BO-Caffeine
Medium and 4 ml of BSA-BO (0.6%) Medium.  The mixture was resuspended and the
tube was placed in the incubator (38ºC) for 10 minutes to equilibrate.
The oocytes were then removed from the Maturation Medium and placed in a
35 x 10-mm Falcon® plastic petri dish containing 2 ml of BSA-BO (0.3%) Medium.
Oocytes were subjected to two washings to remove excess Maturation Medium.  The dish
was then placed back into the incubator at 38.5ºC until the fertilization droplets were
prepared.  The sperm count was considered acceptable for semen use based on the total
number of progressively motile sperm (≥70%).
Next, four 80-µl insemination droplets were made in the 35 x 10-mm Falcon®
plastic petri dish previously labeled and placed into the incubator.  Droplets were covered
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with embryo-tested mineral oil and 10 to 20 oocytes were co-incubated in each
insemination droplet.  The dish was placed into the incubator (38ºC) for a 6-hour period.
Removal of Oocytes from Insemination Droplets
Before oocytes were removed from the insemination droplets, Vortexing Medium,
Oocyte Wash Medium and IVC Medium (day 0 to day 3) were first prepared
(Appendices M, N and O), followed by preparing 35 x 10-mm Falcon® plastic petri
dishes for the fertilized ova.  Oocyte Wash Medium was placed into three separate petri
dishes awaiting the next step of the procedure.
Sperm-exposed ova were then recovered from insemination droplets following the
6-hour co-incubation period and were placed directly into the first dish of Oocyte Wash
Medium.  They were rinsed through the second dish of Oocyte Wash Medium to remove
any excess insemination medium, and they were placed into the 15-ml conical tube of
Vortexing Medium, followed by 3 minutes of vortexing to remove the remaining
cumulus cells.  Then, 2 ml of Oocyte Wash Medium was immediately added to the tube
to stop the enzymatic activity of the hyaluronidase.  The contents of the tube were then
poured into an empty 35 x 10-mm Falcon® plastic petri dish, and the tube was rinsed with
2 ml of Oocyte Wash Medium.  Sperm-exposed ova were then recovered from the dishes
and placed into a final dish of Oocyte Wash Medium.  The dish was placed back into the
incubator (38ºC) while culture droplets were prepared.
IVC Day 0 to Day 3
A petri dish was labeled with the respective treatment group, the time and the
date, followed by adding four, 50-µl droplets of IVC Medium covered with mineral oil.
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Then, 10 to 15 embryos were transferred to each culture droplet, followed by placing the
petri dish in the portable modulator incubator at room temperature (Billups-Rothenberg®,
Del Mar, CA).  The portable incubator was filled with a mixture of 5% CO2, 5% O2 and
90% N2 at 1.4 kg/cm2 (equivalent to 20 pounds per square inch; psi) for 2 minutes.  The
gas chamber was placed into the incubator at 38.5ºC and embryonic development was
recorded 72 hours post-insemination (oocytes were placed into insemination droplets on
day 0).
IVC Day 3 to Day 7
Before evaluating embryonic development, IVC Medium (day 3 to day 7)
(Appendix P) was prepared and allowed to equilibrate for 20 minutes in the incubator.
Embryonic development was recorded and medium was changed at 72 hours of
incubation following insemination.  Embryos were assessed for cleavage patterns and
evidence of degeneration.  The total number of 2-cell, 4-cell, 6 to 8-cell and 16-cell
embryos was recorded.  In addition, embryos that appeared to have degenerated in culture
were counted and then discarded.  The remaining embryos were transferred to a 35 x 10-
mm Falcon® plastic petri dish containing 2 ml of IVC Medium (day 3 to day 7).
Embryos were washed to remove excess medium and by-products generated during the
culture period.
Maturing embryos (n=10 to 15) were transferred into a 50-µl droplet of fresh IVC
Medium (day 3 to day 7) covered with mineral oil.  Petri dishes were then placed back
into the airtight modulator incubator (room temperature) where they were again exposed
to 5% CO2, 5% O2 and 90% N2 for 2 minutes.  The chamber was placed into a humidified
58
5% CO2 incubator at 38ºC until blastocyst development was recorded at 168 hours post-
insemination.
Blastocyst Development
On day-7 post-insemination, embryos were removed from the incubator and the
total number of embryos that reached the blastocyst stage of development were
documented.  Also, embryos either beginning to hatch or that had fully hatched from the
zona pellucida were noted.  Those embryos that developed to the blastocyst and hatching
blastocyst stage were transferred to fresh IVC Medium (day 3 to day 7).  Because the
bovine in vitro developmental block occurs at the 8- to 16-cell stage (Eyestone and First,
1986), those embryos that were not able to overcome this obstacle were discarded.  Petri
dishes were then placed back into the triple gas mixture where embryos were left
undisturbed until 216 hours post-insemination.
Hatching Blastocysts
The final time of embryo evaluation was 216 hours post-insemination.  Embryos
that had completely hatched from the zona pellucida were identified and recorded.
Statistical Analysis
Data for this experiment were analyzed using the Logistic Procedure (SAS, 1992).
The main effects and differences between treatments were considered significant at the
P<0.05 level.  The total number of oocytes that developed to the 2-cell (cleaved),




The total number of oocytes and percentages of embryos successfully reaching
various stages of embryonic development are summarized in Table 4.1.  There were a
total of 120 ovaries aspirated in the Control IVF (Treatment A) and Follicular Fluid
(Treatment B) groups during the experiment.  The total number of oocytes inseminated
from five replicates was 327 and 294 for the Control IVF (Treatment A) and Follicular
Fluid (Treatment B) groups, respectively.
There was no difference in the percentage of degenerated embryos on day 3 post-
insemination detected in the Control IVF group (Treatment A) (4%) compared with that
of the Follicular Fluid group (Treatment B) (18%).  However, a significant difference
(P<0.0001) was detected between Treatments A and B for the total number of oocytes
that cleaved following IVF.  A total of 87% of oocytes that were inseminated underwent
cleavage in Treatment A compared with only 65% of the oocytes cleaving that were
assigned in Treatment B.
Similarly, of a total number of oocytes inseminated in Treatments A (327) and B
(294), a significantly greater percentage (P<0.0001) of oocytes developed to the
blastocyst stage of embryonic development in Treatment A (23%) compared with that for
Treatment B (9%).  In addition, Treatment A had a significantly greater percentage (9%)
of hatched blastocysts compared with that for Treatment B (0%) following IVC for 9
days post-insemination.  Images were recorded to document embryonic development in
Treatments A and B (Figures 4.1 and 4.2).
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*  A = Control IVF, B = Follicular Fluid.
ŧ   Deg = percentage of degenerate embryos.
§   Percentage of blastocysts developed from the total number of oocytes inseminated.
a,bColumns with different superscripts are significantly different (P<0.0001) (Logistic).
1 (0)b 60B 294  53 (18)a 192 (65)b 25 (9)b
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      [72 h]
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       [168 h] §
Hatched (%)
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Table 4.1. Effect of holding bovine oocytes in follicular fluid on embryonic development.
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Figure 4.1. A representative bovine hatching blastocyst from Treatment A
(Control IVF) following IVF.
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 Figure 4.2. Hatched bovine blastocyst from Treatment B (Follicular Fluid).
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Discussion
After analyzing the results from Experiment 1, it was determined that bovine
oocytes were not able to mature after being held in pooled follicular fluid at 38ºC.
Therefore, in this study, an additional maturation medium was used to hopefully bypass
the poor maturation rates observed in Experiment 1.  Results from this study indicated
that oocytes could mature and become fertilized after being held in follicular fluid for 12
hours at room temperature.  However, cleavage and blastocyst rates in the Follicular
Fluid group (Treatment B) were compromised when compared with the Control IVF
group (Treatment A).  Ovary storage conditions (transport, time and temperature) from
the abattoir can be discounted as a possible cause for the low developmental rates in the
Follicular Fluid group (Treatment B), since good IVF embryo production resulted with
the Control IVF group (Treatment A).
Choi et al. (1998) concluded that bovine oocytes could mature and subsequently
be fertilized and develop into viable embryos after exposing them to follicular fluid
collected from small and large follicles.  Nevertheless, blastocyst production was reduced
in the follicular fluid group compared with that of the control group.  However, the only
time oocytes were exposed to follicular fluid was through the in vitro maturation medium
itself.  In a similar study, Romero-Arredondo and Seidel (1996) produced viable bovine
blastocysts after exposing oocytes to follicular fluid in the maturation medium.  These
results indicate that in vitro embryo production is possible even though oocytes have
been exposed to inhibitory substances that may be present in follicular fluid for a short
period of time.
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Although reports have shown that follicular fluid will promote normal embryonic
development, results from our study need to be considered further.  For example, the time
period at which oocytes remained in follicular fluid may not be optimal to promote
normal embryo growth.  Even though oocytes fertilized and cleaved in the Follicular
Fluid group (Treatment B), further embryonic development was compromised when
compared with the acceptable embryo development rate obtained in the Control IVF
group (Treatment A).  Of the 25 blastocysts that were produced in the Follicular Fluid
group (Treatment B), only one embryo hatched out of its zona pellucida.  This illustrates
the unfavorable conditions to which the oocytes were exposed during the pre-maturation
period.  Even though the mechanism that causes this problem is not known, it is likely
that a multitude of factors may be causing premature hardening of the zona pellucida.
Further research is essential to determine the reason(s) causing the embryos not to hatch.
One important factor is the concentration of substances in the follicular fluid that
would decrease oocyte maturation and fertilization.  Hypoxanthine, oocyte maturation
inhibitor and cyclic adenosine monophosphate may have negatively affected the oocytes
before they were placed into a standard maturation medium, as was previously reported
by Bilodeau et al. (1993).  It is a possibility that these inhibitory substance(s) could also
have prevented cytoplasmic maturation from occurring.   The exposure of oocytes to
these substance(s) for 12 hours may have been too long of a time period for subsequent
hatching of embryos following IVF.
When a primary follicle becomes the dominant follicle, inhibin secretion begins
suppressing FSH activity on other follicles on the same follicular wave, likely causing
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their atretic demise (W.-S. et al., 1989).   The underlying process of follicular atresia is
apoptosis, the genetically determined death of follicle cells.  Follicular atresia is a
condition where a number of granulosa cells die, while others remain viable.   This
process undoubtedly impacts the secretion of products into the follicular fluid, ultimately
impairing the developmental competence of oocytes (Jolly et al., 1994).  Since oocytes in
this experiment were collected from ovaries at various stages of the reproductive cycle,
there is a possibility that follicular fluid from atretic follicles was aspirated and placed in
the pool of follicular fluid.
Factors from these atretic follicles contribute, at least in part, to the follicular
environment, which were mixed into the pool of follicular fluid to which the oocytes
were exposed.  Therefore, harmful substances from the process of apoptosis were being
pooled with healthy follicular fluid, rendering some oocytes incapable of normal
development.  However, contradictory results have been reported on the effect of
apoptosis on the development of IVF-derived embryos.  Using an enzyme-linked
immunoassay, Zeuner et al. (2003) were able to identify cumulus oocyte complexes that
were recovered from healthy and atretic follicles.  After adding exogenous follicular cells
from atretic follicles to oocytes during IVM, there was no impact on fertilization,
blastocyst formation or hatching following IVF.  However, there was decreased
blastocyst production when oocytes from atretic follicles were matured in a group
(Blondin and Sirard, 1995).
This study was not able to illustrate the benefits of being able to hold bovine
oocytes in follicular fluid for 12 hours.  However, further investigations are needed to
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determine the reason(s) why embryonic development was inhibited after a specific
holding period in undiluted follicular fluid.
67
CHAPTER V
EFFECT OF HOLDING BOVINE OOCYTES IN FOLLICULAR FLUID OR
LACTATED RINGER’S SOLUTION (LRS) FOR 6 HOURS AT 22ºC ON
EMBRYONIC DEVELOPMENT
Introduction
Follicular fluid originates primarily from peripheral plasma, which has been
modified by the metabolic activities of both the theca interna and granulosa cells (Wise,
1987).  This unique fluid contains various compounds of major physiological
significance, most of which are similar to compounds present in plasma.  Follicular fluid
contains a multitude of proteins, glycoproteins, amino acids, enzymes, carbohydrates,
gonadotropins, steroids, prostaglandins, salts and immunoglobulins, all of which promote
normal physiology within the follicle (Hafez, 2000).
The regulatory function of follicular fluid includes both inhibitory and stimulatory
effects that exert precise control on oocyte maturation, ovulation and subsequent
transport of the oocyte through the oviduct (Edwards, 1974).  Inhibitory substances
include OMI, luteinization inhibitor, FSH receptor-binding inhibitor and inhibin.
Individual components exert their physiological effects with precise timing to ensure
normal oocyte maturation, fertilization and embryonic development.
Oocyte maturation is a complex phenomenon that is still not completely
understood.  However, it is known that oocyte maturation involves a series of three types
of physiological changes.  The first includes nuclear maturation, which involves
cell-cycle regulation.  The second is referred to as cytoplasmic maturation, and involves
both visible and nonvisible changes that take place within the oocyte during its period of
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growth within the follicle.  More recently, a third physiological change has been termed
molecular maturation, and involves the changes that occur after nuclear condensation and
are under the form of mRNA (Sirard, 2001).  It is evident that follicular fluid is only a
small part of the system behind the complex nature of oocyte maturation.  However,
functions of follicular fluid cannot be overlooked when evaluating this substance for in-
the-field use  or for basic research studies.
With the multiple functions attributed by follicular fluid, researchers have used
this biological fluid as a component for in vitro oocyte experiments.  Research has
indicated that follicular fluid collected from follicles <10 mm in diameter inhibited
resumption of meiosis in bovine oocytes (Ayoub and Hunter, 1993; Romero-Arredondo
and Seidel, 1994).  However, these findings may be beneficial for researchers wanting to
utilize this fluid as merely a holding medium before oocytes could be matured using a
standard laboratory maturation medium.  Similarly, Aguilar et al. (2001) concluded that
pure follicular fluid from small follicles (10 to 15 mm in diameter) was able to increase in
vitro maturation rates of equine oocytes.  In these studies, follicular fluid did not exert a
detrimental effect on developmental and meiotic competence of the oocytes.
One could then hypothesize that bovine oocytes could be held in follicular fluid
for a period of time without experiencing harmful effects on the oocyte.  Given the results
of previous research, oocytes would be prevented from maturing while in transport.  This
inhibitory effect on oocytes has been shown to be reversible after exposing bovine
oocytes to a standard laboratory maturation medium (Mermillod et al., 2000).
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Therefore, after analyzing the results from Experiments 1 and 2, an additional
experiment was performed to try to successfully be able to utilize follicular fluid or
Lactated Ringer’s Solution (LRS) as a holding medium. The objective of the final
experiment was to determine the effect of decreasing the time and concentration of bFF
on post-IVF embryonic development.  The specific objective was to determine whether
or not bovine oocytes could be held in follicular fluid or LRS without displaying any
negative effects on subsequent embryonic developmental rates.
LRS was considered as a holding medium in addition to follicular fluid because it
is a balanced (electrolyte concentration similar to serum) and isotonic (osmolality similar
to serum) replacement solution that provides electrolytes in a composition similar to that
of extracellular fluid.  LRS is composed of NaCl, KCl, calcium and lactate, and is easily
available to veterinarians and livestock producers.  Since LRS is a physiologic solution, it
is only logical to assume that it could be utilized as a holding medium for oocytes for a
prolonged period of time.
Being able to utilize follicular fluid or LRS as a holding medium for oocytes
could prove to be an advantageous protocol for producers who have experienced the
untimely death of a genetically superior animal.  Valuable oocytes could be saved and
ultimately used to produce live offspring through the use of IVF.
Materials and Methods
Collection of Ovaries
The abattoir was notified as to the exact time of ovary collection.  The abattoir
confirmed the species, breed type and approximate age of the animals from which the
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ovaries were to be harvested.  Ovaries were requested to be from mature, cycling cows
rather than from immature heifers.  Most of the ovaries used for this experiment were
collected from dairy-type cows, consisting of Holstein and Jersey breeds, although a few
cows of beef breeds were also processed.  The abattoir immediately placed the harvested
pair of ovaries in a container filled with 500 ml of Ovary Transport Medium (Appendix
A).
Once the technician arrived at the abattoir, the ovaries were recovered from the
holding container and fresh Ovary Transport Medium was poured into a plastic Ziploc®
bag.  The ovaries were then thoroughly cleansed in the medium.  Then, ovaries were
wiped with ethanol-soaked gauze pads to remove any remaining debris from the slaughter
process.  The harvested pairs of ovaries were then placed into a second plastic bag
containing 500 ml of fresh Ovary Transport Medium.  The ovaries were transported to
the laboratory at 22ºC to 25ºC within 6 to 8 hours after the first set of ovaries had been
collected at the abattoir.
Aspiration of Follicle Populations
Upon arrival to the laboratory, ovaries were removed from the collection bag and
placed onto a sterile drape.  They were once again subjected to a thorough cleansing
process including wiping them with ethanol-soaked gauze pads in addition to fresh Ovary
Transport Medium.  Ovaries were first examined to determine the degree of follicular
development and also the presence of reproductive structures, such as pre-ovulatory
follicles and luteal tissue structures before assigning ovaries to treatment groups.  All
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harvested ovaries were utilized during the experiment except for those lacking visible
follicles.
All follicles 2 to 9 mm in diameter were punctured using a 20-gauge, 37.5-mm
needle (Kendall, Mansfield, MA) connected to a 12-ml disposable syringe (Sherwood
Davis and Geck, St. Louis, MO).  Ovaries were continuously wiped with ethanol-soaked
gauze pads to prevent contamination to the ovarian surface.  After all visible follicles
were punctured, the aspirates were then pooled and dispensed into 6-ml, 75-mm Falcon®
centrifuge tubes (Becton Dickinson, Lincoln Park, NJ).  The tubes were carefully labeled
with the respective treatment group, the time and the date.  Aspiration of all follicles from
the recovered ovaries took <45 minutes to complete.
Experimental Design
All ovaries used in the experiment were randomly assigned to either one of four
treatment groups.  Ovaries randomly assigned to Treatment A (Control IVF), were
aspirated, the follicular aspirate was searched and recovered oocytes were placed directly
into Maturation Medium (Appendix E) for 22 hours, followed by IVF.  The ovaries
randomly assigned to Treatment B (Follicular Fluid) were punctured and the aspirate was
pooled and immediately dispensed into a 6-ml, 75-mm centrifuge tube that has been
previously labeled with the respective date and the treatment group.  The follicular
aspirate that was recovered for Treatment C (LRS) was pooled and then placed into a
different 6-ml, 75-mm centrifuge tube.  Utilizing LRS in Treatment C served as a control
for the Follicular Fluid (Treatment B) group.  Since oocytes in Treatment C were never
exposed to follicular fluid, the effect of follicular fluid on embryonic development could
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be evaluated.  Lastly, the aspirate recovered from those ovaries reserved for Treatment D
(Follicular Fluid + LRS) was pooled and placed into a labeled 6-ml, 75-mm centrifuge
tube.  Then, the oocytes were placed into the 75-mm treatment tubes before the pre-
maturation time interval began.  Follicular aspirates from all treatment groups were held
at room temperature during processing.
Experimental Procedure
The first step was to dispense precisely 3 ml of LRS (Abbott Laboratories,
Chicago, IL) into a 6-ml, 75-mm Falcon® centrifuge tube.  Next, the pooled follicular
aspirate obtained for Treatment C was poured into a 100, 15-mm Falcon® square plastic
search dish (Becton Dickinson, Lincoln Park, NJ).  Oocytes were recovered and placed
into a previously prepared 35 x 10-mm Falcon® plastic petri dish (Becton Dickinson,
Lincoln Park, NJ) containing 2 ml of LRS using a hand pulled pipette with an outside
diameter of 100 to 200 µm.  Oocytes were washed through this medium before they were
placed into the tube containing 3 ml of LRS.
Next, a separate 6-ml, 75-mm Falcon® centrifuge tube was prepared by mixing 1.5
ml of the LRS with 1.5 ml of follicular fluid obtained from the follicle aspiration process
for Treatment D to give a final volume of 3 ml.  The remainder of the aspirate was
searched and recovered oocytes were placed directly into 3 ml of a combination of
follicular fluid and LRS.  The original tube containing the aspirate from Treatment B was
left undisturbed and was not filtered while the above procedure was conducted.  This
allowed pellet formation of the recovered oocytes and cumulus cells.  The supernatant of
follicular fluid was aspirated until a final volume of 3 ml was achieved.
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The three tubes from Treatments B, C and D were wrapped with aluminum foil to
prevent exposure to light.  They were then placed in a test tube rack where they were held
for a 6-hour pre-maturation period at room temperature (22ºC).  After the pre-maturation
period, oocytes from each group were allowed to mature in a standard laboratory
Maturation Medium followed by IVF.  The timeline established for individual treatment
groups is presented in Figure 5.1.
Maturation of Oocytes
Follicular fluid recovered from the ovaries obtained for the Control IVF group
(Treatment A) was first poured into a 100 x 15-mm Falcon® plastic dish.  The tube was
then thoroughly rinsed with pre-equilibrated Maturation Medium to make certain all
oocytes were removed from the inside of the collection tube.  Recovered oocytes were
pipetted into a 35 x 10-mm Falcon® plastic petri dish containing fresh Maturation
Medium using a 225-mm Pasteur pipette (Fisher ScientificTM, Pittsburgh, PA).  After
thoroughly washing the oocytes, they were then placed into 50-µl droplets of Maturation
Medium covered with embryo-tested mineral oil (M-8410, Sigma Chemical Co., St.
Louis, MO).  Oocytes (n=10 to 15) were put into each micro droplet.  The oocytes were
then placed into a humidified incubator at 38ºC and 5% CO2 in air for 22 hours.
After a 6-hour pre-maturation period for Treatments B, C and D, the tubes
containing the follicular contents were individually searched and oocytes were transferred
into Maturation Medium.  Petri dishes were labeled with the corresponding treatment
group, the time and the date.  Oocytes were allowed to undergo a 22-hour maturation
interval.
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Figure 5.1.  Timeline of the events occurring for Treatments A, B, C and D.
Ovary
Collection
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Preparation of Semen
Fertilization Medium, BO-Caffeine Medium, BSA-BO (0.6%) Medium and BSA-
BO (0.3%) Medium were prepared prior to the start of the experiment (Appendices I, J, K
and L).
After allowing the medium to equilibrate, the semen was prepared for the IVF
procedure.  A 35 x 10-mm Falcon® plastic petri dish was labeled and placed into the
incubator to avoid temperature shock to the sperm when added.  A water bath (40ºC to
41ºC) was prepared to thaw the straw of semen.  The semen used for this experiment was
obtained from two fertile Holstein bulls (CSS 7H5188 and 7H5673, Genex Cooperative,
Inc., Shawano, WI).  In replicates one through four, the bull identification number was
7H5188.  For the remaining four replicates, semen was used from a bull with the
identification number 7H5673.
Frozen sperm was instantly placed into a warm water bath for ~45 seconds to
thaw.  Once thawed, the contents of the straw were dispensed into a 15-ml plastic conical
tube (Corning, New York, NY).  Then, 9 ml of pre-equilibrated BO-Caffeine Medium
was combined with the semen.  The tube was then centrifuged at 200 x g for 6 minutes.
The supernatant was carefully discarded, to make sure the pellet of sperm cells was not
disrupted.  Another 9 ml of the BO-Caffeine Medium was added to the tube, followed by
gently pipetting the mixture to resuspend the pellet.  The contents of the tube were
centrifuged for a second time at 200 x g for 6 minutes.  The supernatant was then
removed and the sperm cells were washed with an additional mixture of 4 ml of BO-
Caffeine Medium and 4 ml of BSA-BO (0.6%) Medium.  The final combination of sperm
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cells and medium were resuspended and placed into the incubator for 10 minutes for
proper equilibration.
The oocytes were removed from Maturation Medium and pipetted into a 35 x
10-mm Falcon® plastic petri dish containing 2 ml of BSA-BO (0.3%) Medium.  Oocytes
were washed of excess medium and the dish was then placed back into the incubator until
insemination droplets were prepared.  To determine the number of progressively motile
sperm, a count was conducted and droplets were prepared if motility was acceptable
(≥70%).  Ultimately, four 80-µl insemination droplets were prepared in the previously
labeled 35-mm petri dish and covered with embryo-tested mineral oil.  Then, 10 to 20
oocytes were placed into each individual insemination droplet.  The sperm and oocytes
were allowed to co-incubate for 6 hours at 38ºC and 5% CO2  in air.
Oocyte Removal from Insemination Droplets
 First, Vortexing Medium, Oocyte Wash Medium and IVC Medium (day 0 to
day 3) were made for use (Appendices M, N and O).  Then, 35 x 10-mm Falcon® plastic
petri dishes were prepared with Oocyte Wash Medium.  Sperm-exposed ova were
removed from the insemination droplets and placed into the first dish containing Oocyte
Wash Medium.  These ova were washed twice to remove debris from the insemination
process.  They were then pipetted into the 15-ml plastic conical tube containing
Vortexing Medium and vortexed for 3 minutes.  Immediately following, 2 ml of Oocyte
Wash Medium was added to the tube to halt the enzymatic activity of the hyaluronidase.
The tube was then rinsed with 2 ml of Oocyte Wash Medium to obtain any embryos left
behind during the procedure.  Embryos were finally recovered and subjected to one more
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washing.  The 35-mm petri dish was placed back into the incubator until IVC droplets
were prepared.
IVC Day 0 to Day 3
Embryos (n=10 to 15) were placed into individual droplets of IVC Medium (day 0
to day 3) covered with mineral oil.  The petri dishes were placed into the portable
modulator incubator (Billups-Rothenber, Del Mar, CA).  A gas mixture consisting of 5%
CO2, 5% O2 and 90% N2 was filled into the chamber at 1.4 kg/cm2, which is equivalent to
20 psi for 2 minutes.  The triple gas chamber was then placed into the incubator and
cleavage was assessed 72 hours post-insemination (oocytes were placed into insemination
droplets on day 0).
IVC Day 3 to Day 7
IVC Medium (day 3 to day 7) was prepared (Appendix P) and allowed to
equilibrate for 20 minutes.  Embryonic development was then documented using a Nikon
SMZ-2B stereoscopic microscope (Nikon, Tokyo, Japan).  Embryos were assessed at the
2-cell, 4-cell, 6- to 8-cell and 16-cell stages.  Embryos that had degenerated during the
culture period were recorded and discarded from the experiment.
Viable appearing embryos were washed through a 35 x 10-mm Falcon® plastic
petri dish containing 2 ml of IVC Medium (day 3 to day 7) using a hand-pulled pipette
with an outside diameter of 200 to 250 µm to remove excess culture medium.  Then, 10
to 15 embryos were pipetted into separate 50-µl droplets of IVC Medium (day 3 to day
7).  Petri dishes were then placed back into the portable incubator where they were
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exposed to 5% CO2, 5% O2 and 90% N2 for 2 minutes.  The chamber was returned to the
incubator until blastocyst development could be assessed at 168 hours post-insemination.
Development of Blastocyst-Stage Embryos
Following 7 days of IVC, the total number of embryos that had reached the
blastocyst stage of development were recorded.  Those embryos that were hatching from
the zona pellucida were also noted.  In addition, blastocyst quality grades (QG) were also
recorded.  A QG-1 blastocyst was considered to have a tight inner cell mass (ICM) with
no displaced cells and no extruded cells.  A QG-2 blastocyst was considered to be an
embryo that had some displaced ICM cells or extruded cells.  Blastocysts that were
classified as QG-3 had displaced ICM cells and extruded cells.  The QG-4 classification
was assigned to an embryo that displayed marked displacement of ICM cells and
contained many extruded cells.
Only healthy embryos were transferred to fresh IVC Medium (day 3 to day 7)
using a hand-pulled pipette (outside diameter of 250 to 300 µm) for an additional 2 days.
Embryos that were not able to overcome the in vitro developmental block were discarded.
Petri dishes were returned to the triple gas mixture until 216 hours post-insemination.
Final evaluation of in vitro embryo development was completed 9 days following
insemination.  Embryos that had completely hatched out of the zona pellucida were
identified and images were recorded to denote the endpoint of the experiment.
Statistical Analysis
Data for this specific experiment were analyzed using the Logistic and Frequency
Procedures (SAS, 1992).  The main effects and differences were considered significant at
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the P<0.05 level.  The total number and percentage of oocytes that had developed to the
2-cell (cleaved), blastocyst and hatched blastocyst stages along with blastocyst quality
grades were used to evaluate and compare treatments.
Results
The total number of oocytes and percentage of embryos reaching various stages of
embryonic development following IVF are summarized in Table 5.1.  Photographic
images were recorded from each treatment group to show different phases of embryonic
growth (Figures 5.2, 5.3, 5.4 and 5.5).  In this study, 32 ovaries were aspirated to obtain
oocytes for each of the four treatment groups.  The total number of oocytes recovered
following eight replicates was 340, 335, 297 and 310 for the Control IVF (Treatment A),
Follicular Fluid (Treatment B), LRS (Treatment C) and FF + LRS (Treatment D) groups,
respectively.  The number and percentage of degenerated embryos for Treatments A, B,
C and D were 20 (6%), 25 (7%), 101 (34%) and 60 (19%), respectively.  The number and
percentage of blastocysts produced during this study following 7 days of IVC were 88
(26%), 85 (25%), 14 (5%) and 48 (15%) for Treatments A, B, C and D, respectively.  The
number and percentage of hatched blastocysts produced following 9 days of IVC for
Treatments A, B, C and D were 58 (17%), 58 (17%), 6 (2%) and 26 (8%), respectively.
There was no significant difference in embryo degeneration rates noted among the
four treatment groups when observed 72 hours post insemination.  There was no
significant difference (P>0.05) in cleavage rates detected between the Control IVF
(Treatment A) (89%) and Follicular Fluid (Treatment B) (86%) groups following IVF.
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         *      A = Control IVF, B = Follicular Fluid, C = LRS, D = FF + LRS.
         §      Percentage of degenerate embryos.
         ŧ       Percentage of blastocysts developed from the total number of oocytes inseminated.
         a,b,cColumns with different superscripts are significantly different (P<0.0001) (Logistic).
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Table 5.1. The effect of bovine follicular fluid or Lactated Ringer’s Solution holding
medium on subsequent bovine in vitro embryonic development.
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Figure 5.2. IVF-derived bovine blastocysts (day 7) from Treatment A (Control IVF).
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  Figure 5.3. IVF-derived bovine hatched blastocysts (day 9) from Treatment B
  (Follicular Fluid).
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Figure 5.4. IVF-derived bovine hatched blastocyst (day 9) from Treatment
C (Lactated Ringer’s Solution).
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Figure 5.5. A representative IVF-derived bovine embryo (day 9) from
Treatment D (Follicular Fluid + Lactated Ringer’s Solution).
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However, the number of oocytes that cleaved in the LRS (Treatment C) (45%) and FF +
LRS (Treatment D) (68%) groups was significantly less (P<0.0001) than the Control IVF
and Follicular Fluid groups (Treatments A and B).  Furthermore, there were a
significantly greater (P<0.0001) number of cleaved oocytes in the FF + LRS (Treatment
D) group when compared with that of the LRS (Treatment C) group.
Furthermore, there was no significant difference (P>0.05) in blastocyst formation rate 7
days post-insemination between Treatment A (26%) and Treatment B (25%).  However,
there were significantly fewer (P<0.0001) embryos reaching the blastocyst stage in
Treatment C (5%) and Treatment D (15%) when compared with those in Treatment A
(26%) and Treatment B (25%) following IVC.  However, there was a greater percentage
of embryos developing to the blastocyst stage in Treatment D when compared with that
of the LRS (Treatment C).
In this study, there was no significant difference (P>0.05) noted in blastocyst
hatching rates between the Control IVF group (Treatment A) (17%) and the Follicular
Fluid group (Treatment B) (17%).  However, there was a significantly lower (P<0.0001)
percentage of embryos that hatched in the LRS group (Treatment C) (2%) and FF + LRS
group (Treatment D) (8%) when compared with the Control IVG group (Treatment A)
and Follicular Fluid group (Treatment B).  Furthermore, significantly fewer (P<0.0001)
embryos hatched in the LRS group (Treatment C) when compared with those in the FF +
LRS (Treatment D) group.  Similarly, significantly fewer (P<0.0001) embryos hatched in
the LRS group (Treatment C) when compared with those in the FF + LRS group
(Treatment D).
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Blastocyst quality grades on 7 days post-insemination are presented in Table 5.2.
There was no difference between the percentage of QG-1 blastocyts in Treatment A
(43%) and Treatment B (41%) when compared with Treatment C and Treatment D.
However, there were significantly fewer (P<0.05) QG-1 blastocysts in Treatment C (0%)
and Treatment D (8%) when compared with Treatment A and Treatment B.
The percentage of QG-2 blastocysts was significantly less (P<0.05) in Treatment
C (7%) when compared with Treatment A (44%), Treatment B (44%) and Treatment D
(63%).  Also, there were significantly more (P<0.05) QG-2 blastocysts in Treatment D
than in Treatments A and B.
There was no significant difference (P>0.05) in the number of QG-3 blastocysts
between Treatment A (13%) and Treatment B (15%).  However, there was a significant
difference (P<0.05) in the number of QG-3 blastocysts between Treatment B (15%) and
Treatment D (29%).  There were significantly fewer (P<0.05) QG-3 blastocysts in
Treatment A (13%) compared with Treatment C (79%) and Treatment D (29%).  Also,
there were fewer QG-3 embryos in Treatment B (15%) when compared with Treatment C
(79%).  However, Treatment D (29%) had significantly fewer (P<0.05) QG-3 embryos
than Treatment C (79%).
Discussion
While the IVF results produced in Experiment 2 were less than optimal for
oocytes held in follicular fluid, embryo development rates in Experiment 3 was markedly
increased in the Follicular Fluid group.  The results from the present study indicate that
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Table 5.2. The effect of bovine follicular fluid or Lactated Ringer’s Solution holding
medium on blastocyst quality grades of IVF-derived bovine embryos.
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one factor inhibiting oocyte maturation, fertilization and embryonic development was the
amount of time oocytes were exposed to the pool of undiluted follicular fluid.
Decreasing the holding period to only 6 hours in this experiment rather than 12 hours as
in Experiment 2 proved to be favorable for oocyte viability.
The results from Experiment 2 also suggested that the high concentration of
follicular fluid could have attributed to the decreased embryo development rates.
However, the results recorded for the LRS group and the FF + LRS group illustrate that
embryo development was significantly decreased when the concentration of follicular
fluid was reduced during the holding period.  This finding is similar to that of Elmileik et
al. (1995), who reported that bovine blastocyst rates increased from 27% when follicular
fluid was not supplemented to the maturation medium to 36% when follicular fluid was a
component of the maturation medium.  Similarly, Chauhan et al. (1997) also found that
the an increased concentration of follicular fluid supplemented to the maturation medium
of water buffalo oocytes increased the blastocyst yield from 25% when only 20%
follicular fluid was used to 31% when 40% follicular fluid was supplemented to the
maturation medium.
Results from our study indicate that follicular fluid was a suitable choice for a
pre-maturation medium, as indicated by a greater number of excellent quality blastocysts
in the Control IVF and Follicular Fluid groups compared with the LRS and FF + LRS
groups.  This finding suggests that the exposure of oocytes to follicular fluid during the 6-
hour pre-maturation period allowed for acceptable blastocyst production and quality.
Results from our study correspond with those found by Elmileik et al. (1995) who
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reported that significantly more bovine blastocysts were produced following in vitro
maturation in medium supplemented with follicular fluid.  When follicular fluid was not
supplemented to the maturation medium, only 27% blastocyst formation was recorded.
However, when follicular fluid was supplemented to the medium, there was a 36%
blastocyst yield.  These findings suggested that follicular fluid contained stimulatory
substance(s) that during maturation promoted bovine oocytes to develop to the blastocyst
stage following IVF.
Embryo quality was compromised in the LRS group when there was a lack of
follicular fluid bathing the oocytes for the 6-hour time interval.  This suggests that
follicular fluid was beneficial in the holding medium, since acceptable embryo
development and quality rates were obtained.  This finding agrees with that of Pinto et al.
(2002), where it was concluded that bovine oocytes could be maintained in equine
follicular fluid for 6 hours prior to maturation without detrimental effects on IVF-derived
embryos.
Although oocytes were inhibited from maturing during the pre-maturation in
follicular fluid, standard maturation protocols initiated GVBD, leading to mature oocytes
that could be fertilized in vitro.  Lonergan et al. (1997) confirmed that bovine oocytes
could resume meiosis after an inhibitory period of 24 hours in cycloheximide, a known
inhibitor of meiosis.  The inhibitory effect was found to be fully reversible after exposing
oocytes to a standard maturation medium.  This finding illustrates the feasibility of in
vitro meiotic inhibition as a tool in the study of the mechanisms involved in the
acquirement of developmental competence (Lonergan et al., 1997).  Furthermore, it
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confirms that even though oocytes in the Follicular Fluid, LRS and FF + LRS groups
may have been inhibited from maturing for 6 hours, the effects of the follicular
components could be overcome by a follow-up period of IVM.
Unlike the findings in Experiment 2, this experiment illustrated the full
developmental capacity of oocytes retrieved from animals that have been deceased for 6
hours.  This finding coincides with a report from Blondin et al. (1997), who reported that
a greater percentage of bovine blastocysts were produced from oocytes that had been held
in the ovaries for at least 4 hours following slaughter.  Their study supports the existing
hypothesis that the developmental competence of a bovine oocyte is acquired before the
oocyte ever undergoes in vitro maturation.
Although evident postmortem degenerative changes occur within the follicle and
oocyte soon after the death of an animal, the culture system described in this experiment
allowed for oocytes to reverse the degenerative changes that occur during maturation and
subsequent fertilization.  This finding is similar to a report by Schroeder et al. (1991),
who found that there was a reversal of postmortem degeneration of mouse oocytes that
were recovered from ovaries that had been stored for up to 6 hours following the death of
the animal.
Carolan et al. (1994) reported that, on average, 15.4 embryos could be produced
from oocytes harvested from a single slaughtered cow.   This report clearly illustrates that
a considerable number of oocytes could be rescued from terminal animals, and
subsequently salvaged for use to preserve genetic material.  With this in mind, the
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outcome of Experiment 3 becomes beneficial from a practical aspect of rescuing oocytes
from a genetically valuable female.
The results from this experiment demonstrated the feasibility of storing oocytes
for a short interval to allow for transport to a veterinary clinic where oocytes could be
subjected to advanced reproductive techniques.  Storage of oocytes for 6 hours in
follicular fluid at 22ºC may be important for the rescue of oocytes from recently deceased




Although in vitro embryo production systems have been improved over the last 50
years, it should be noted that the natural environment from which oocytes are obtained
will likely yield better maturation, fertilization and embryonic development rates.  For an
in vitro embryo production system to become optimal, several factors must be taken into
consideration.  Follicle selection, oocyte quality and competence, media supplementation
and culture conditions are only a few to keep in mind.  Numerous experiments have been
reported regarding in vitro fertilization systems for large and small domestic animals,
however, there is still no report of any one system that surpasses the rest.  The present
study analyzed the effects of using undiluted follicular fluid at various times and
temperatures as a holding medium for which oocytes could remain for a realistic period
of time before being matured and fertilized.
The principal objective of using bovine follicular fluid as a holding medium
originates from the fact that the death of a valuable animal is often an untimely event.
Being able to hold oocytes in the fluid from which they initially originated could serve as
a useful medium to preserve valuable genetic material until an embryo production
laboratory could be available to perform advanced reproductive techniques, such as IVF.
It was evident from the results of our first experiment that this medium would be
detrimental when trying to rescue oocytes from deceased females.  Although nuclear
maturation rates did not differ between the Control and Follicular Fluid groups, there
were no viable oocytes present following their storage in follicular fluid.  One
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explanation for this finding would be that the temperature at which the oocytes were
maintained for 12 hours was promoting various metabolic activities, which contributed to
the demise of the oocytes.  Another consideration is the amount of time at which oocytes
were exposed to the bovine follicular fluid.  This was possibly due to too many inhibitory
substances in the follicular fluid over a 12-hour period of time that had a negative
influence on the oocytes.  Inhibitory factors may have come from autolysis of the
follicular cells or simply from the metabolic by-products of the oocytes.  The negative
results displayed in the first experiment can only be speculated on at this time.  However,
further research could prove to be helpful in understanding the mechanism that causes
oocytes to die in follicular fluid held at 38°C for 12 hours.
In the second experiment, follicular fluid tended to be less harmful when oocytes
were held at 22°C for 12 hours.  This was likely due to a decrease in the temperature at
which the oocytes were exposed during the pre-maturation period.  However, utilizing
follicular fluid as a holding medium still proved to be suboptimal on developmental rates
of IVF-derived bovine embryos.  Although blastocyst formation was observed in the
Follicular Fluid (Treatment B) group, the rates were significantly decreased when
compared with those oocytes that had not been exposed to the in vitro follicular fluid
environment.
An interesting observation was noted in those embryos that had developed from
oocytes held in follicular fluid.  Of the blastocyts that developed, only 1 of 25 embryos
was able to hatch during in vitro culture of 9 days.  The remainder were allowed to
culture for a prolonged period (14 days) of time, still to find no further development.
94
This observation may have been due to certain substances that contributed to premature
zona pellucida hardening.  However, holding oocytes in follicular fluid for 12 hours at
room temperature did not prove to be a worthy medium in which to hold oocytes before
performing standard IVF procedures.
The final experiment of this study concluded that embryo developmental potential
was not hindered when only exposing oocytes to undiluted follicular fluid for 6 hours at
room temperature.  With no significant differences detected between the Control IVF and
Follicular Fluid groups, it was concluded that oocytes could be held in this medium
without affecting an embryo’s ability to develop in vitro.  Also, considering the decreased
cleavage, blastocyst and hatching rates in the LRS group, it could also be concluded that
follicular fluid can be beneficial to oocytes for a short period of time.  Undiluted
follicular fluid proved to be less detrimental compared with decreasing the concentration
in half as illustrated by the decreased rates noted in the Follicular Fluid + LRS group.
Although it has been shown that follicular fluid inhibits nuclear maturation, a holding
period of 6 hours in follicular fluid followed by a standard in vitro maturation period can
overcome the negative effects exerted by the follicular fluid.
Being able to hold oocytes in the dynamic environment of follicular fluid may
prove to be useful for in-the-field purposes.  The results obtained from the final study
illustrated that oocytes could be maintained for up to 6 hours without damaging the
ability of the oocytes to develop into a viable embryo following IVF.  Producers could
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APPENDIX: TRANSPORT, MATURATION AND IVF MEDIA
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A: OVARY TRANSPORT MEDIUM
Component (Product Information) Amount
0.9% sterile saline  500 ml
Gentamicin (15750-060, Gibco, Grand Island, NY)     50 µl
B: OOCYTE HOLDING MEDIUM
Component (Product Information) Amount
TL-HEPES (TLH; BioWhittaker, Walkersville, MD)           45 ml
Fetal Bovine Serum (FBS; Hyclone Laboratories, Logan, UT)           10%
Gentamicin         1 µl/ml
Place into warm water bath 20 minutes before use.
C: OOCYTE DENUDING MEDIUM
Component (Product Information)   Amount
Tissue Culture Medium-199 (Gibco Laboratories, Grand Island, NY)   10 ml
Hyaluronidase (H-3506, Sigma Chemical Co., St. Louis, MO)             0.012 g
Filter media using a 0.2-µm sterile filter (Pall Corporation, Ann Arbor, MI) attached to a
12 ml disposable syringe.  Place into a warm water bath 20 minutes before use.
D: OOCYTE STAINING MEDIUM
Component (Product Information) Amount
TL-HEPES buffer    2 ml
Bis-benzimide (Hoechst-33342; Sigma Chemical Co., St.Louis, MO)      4 µl
Wrap with aluminum foil to avoid light exposure and place into incubator 20 minutes
before use.
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E: OOCYTE MATURATION MEDIUM
Component (Product Information) Amount
TCM-199 8.835 ml
Bovine Follicle Stimulating Hormone (FSH; NOBL Laboratories,
Sioux Center, IA) Stock 0.020 ml
Bovine Luteinizing Hormone (LH; NOBL Laboratories, Sioux 
Center, IA) Stock 0.125 ml 
FBS     1.0 ml
Gentamicin 0.010 ml
Estradiol-17β (E2; Sigma Chemical Co., St. Louis, MO) 0.010 ml
Hormone Stocks
FSH: 1 vial contains 490 IU (35 mg)
Reconstitute with 14 ml TCM-199 to give a 2.5-mg/ml stock (35 IU/ml)
LH: 1 vial contains 30,000 IU (8 mg)
Reconstitute with 10-ml TCM-199 to give a 0.8 mg/ml stock (3000 IU/ml)
E2: Add 10 mg of E2 to 10 ml of 95% ethanol to give a 1 mg/ml
stock.  Store at -80ºC.  Discard after 4 weeks.
Medium Preparation
1. Add 8.835 ml of TCM-199, 0.020 ml of FSH stock, 0.125 ml of LH stock, 1 ml of FBS
and 0.010 ml of Gentamicin to a 15-ml conical tube (Corning, New York, NY). Sterile
filter.
2. Add 0.010 ml E2 stock.
3. Prepare two 35-mm petri dishes with 2 ml of maturation medium to be used as a wash
medium.
4. Prepare 50-µl maturation droplets of filtered medium under embryo-tested mineral oil
and allow to equilibrate in incubator at 38ºC and 5% CO2 for at least 3 hours.
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F: BO-A STOCK SOLUTION
Component (Product Information)         Amount
NaCl (S-5886, Sigma Chemical Co., St. Louis, MO) 4.3902 g
KCl (P-5404, Sigma Chemical Co., St. Louis, MO) 0.1974 g
CaCl2 2H2O (C-7902, Sigma Chemical Co., St. Louis, MO) 0.2171 g
NaH2PO4 H2O  (S-9638, Sigma Chemical Co., St. Louis, MO) 0.0743 g
MgCl2 6H2O (M-2393, Sigma Chemical Co., St. Louis, MO) 0.0697 g
Milli-Q Water (Millipore CorporationTM, Bedford, MA)    500 ml
Phenol Red (0.5%) (P-0290, Sigma Chemical Co., St. Louis, MO)   0.10 ml
Prepare the medium in a 500-ml bottle and store in the refrigerator for up to 3 months.
Cover the bottle with parafilm to help maintain the pH.
G: BO-B STOCK SOLUTION
Component (Product Information) Amount
NaHCO3 (S-8875, Sigma Chemical Co., St. Louis, MO) 2.5873 g
Milli-Q Water    200 ml
Phenol Red (0.5%)   0.04 ml
Prepare the medium in a 250-ml bottle.  Next, inject CO2 gas into the bottle for 1 to 2
minutes until a color change occurs.  Cover the bottle with parafilm to help maintain the
appropriate pH.  Store in the refrigerator for no more than 3 months.
H: CR1aa STOCK SOLUTION




Pyruvic Acid (P-4562, Sigma Chemical Co., St. Louis, MO) 0.0044 g
L-Lactic Acid (L-4388, Sigma Chemical Co., St. Louis, MO) 0.0546 g
Glycine (G-8790, Sigma Chemical Co., St. Louis, MO) 0.0039 g
L-Alanine (A-7469, Sigma Chemical Co., St. Louis, MO) 0.0045 g
Milli-Q Water    100 ml
Phenol Red (0.5%)     0.2 ml
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Prepare the medium in a 100-ml bottle then sterile filter using a 0.2-µm filter into two 50-
ml conical tubes Corning, New York, NY).  Cover the tubes with parafilm and store in
the refrigerator for up to three months.
I: FERTILIZATION MEDIUM (BO-AB)
Component (Product Information) Amount
BO-A Stock   38 ml
BO-B Stock   12 ml
Pyruvic acid        0.00685 g
Gentamicin   50 µl
Heparin Sodium (Elkins-Sinn, Cherry Hill, NJ)   18 µl
Prepare medium in a 50-ml plastic conical tube (Corning, New York, NY).
J: BO-CAFFEINE SOLUTION
Component (Product Information) Amount
Caffeine Sodium (C-4144, Sigma Chemical Co., St. Louis, MO) 0.0243 g
BO-AB      25 ml
Prepare medium in a 50-ml conical tube, sterile filter then place into a warm water bath
until needed for semen preparation.
K: BSA-BO (0.6%) SOLUTION
Component (Product Information) Amount
Bovine Serum Albumin (A-7511, Sigma Chemical Co., St. Louis, MO)   0.03 g
BO-AB      5 ml
Prepare medium in a 15-ml conical tube, sterile filter then place into an incubator for a
15-minute equilibration period.
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L: BSA-BO (0.3%) SOLUTION
Component Amount
BSA   0.03 g
BO-AB    10 ml
Prepare medium in a 15-ml conical tube, sterile filter and allow for a 15-minute
equilibration period in the incubator.
M: VORTEXING MEDIUM
Component Amount
TCM-199      1 ml
Hyaluronidase            0.0010 g
Prepare the medium and then place into incubator prior to adding the oocytes.
N: OOCYTE WASH MEDIUM
Component Amount
TCM-199   10 ml
BSA   0.03 g
Prepare the medium, sterile filter then place into incubator for a 20-minute equilibration
period.
O: IVC MEDIUM (DAY 0 TO 3) (Rosenkrans and First, 1994)
Component (Product Information) Amount
CR1aa Stock   9.5 ml
BMEaa solution (B-6766, Sigma Chemical Co., St Louis, MO)   200 µl
MEMaa solution (11140-050, Gibco Laboratories, Grand Island, NY)   100 µl
Gentamicin     10 µl
L-Glutamine (G-5763, Sigma Chemical Co., St. Louis, MO)          0.00146 g
BSA    0.03 g
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Prepare culture medium in a 15-ml conical tube, sterile filter and pre-equilibrate in the
incubator for 20 minutes.
P: IVC MEDIUM (DAY 3 TO 7) (Rosenkrans and First, 1994)
Component Amount
CR1aa Stock  9.5 ml
BMEaa solution  200 µl
MEMaa solution  100 µl
Gentamicin    10 µl
L-Glutamine         0.00146 g
BSA   0.03 g
FBS  500 µl
Prepare culture medium in a 15-ml conical tube, sterile filter and pre-equilibrate in the
incubator for 20 minutes.
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